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Cervical cancer is the second most common cancer in women worldwide and is mainly 
caused by the human papillomavirus (HPV). The purpose of this study was to determine 
whether there was a statistically significant difference in the diagnosis of cervical cancer 
in women who received the HPV vaccine compared to women who did not receive the 
vaccine, while considering demographic factors (race, ethnicity, level of education, 
household income), personal risk factors (sexual orientation, cigarette use, diet, and type 
of contraception use), and factors affecting access to healthcare (type of healthcare 
coverage, delay in receiving medical care). This research study, guided by the social 
cognitive theory, consisted of secondary data analysis from the 2017 Behavioral Risk 
Factor Surveillance System for the females ages 18 to 60 who were diagnosed with 
cervical cancer as well as those who tested negative for cervical cancer. Females may or 
may not have received the HPV vaccine. Data were analyzed using binomial logistic 
regression analysis. Ethnicity was a significant predictor of cervical cancer diagnosis, B = 
-1.93, OR = 0.15, p < .001, indicating that Hispanic individuals were 0.15 times as likely 
to have a diagnosis of cervical cancer. Based on the findings of this study, health care 
organizations may wish to raise awareness of cervical cancer among certain ethnic or 
racial groups. Furthermore, there could be a more proactive approach to cervical cancer 
prevention and detection. The potential positive social change that could result from this 
study is increased rate and timely administration of HPV vaccination for women, which 
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Chapter 1: Introduction to the Study 
Cervical cancer is the second most common cancer in women worldwide and is 
mainly caused by the human papillomavirus (HPV; Fisher & Brundage, 2009; Hughes, 
2009). Cervical cancer accounted for 9% (529,800) of the total new cancer cases 
worldwide and 8% (275,100) of the total cancer deaths among females in 2008 (Jemal et 
al., 2011). In the year 2017, 12,820 women in the United States were diagnosed with 
cervical cancer, and there were 4,210 deaths (American Society of Clinical Oncology 
[ASCO], 2018). Further, more than 85% of cervical cancer cases and deaths occur in 
developing countries. India, the second most populous county in the world, accounts for 
27% (77,100) of the total cervical cancer deaths (ASCO, 2018). Preventive measures are 
needed and therefore the HPV vaccine is recommended for females between 13 and 60 
years of age (Lindau et al., 2001).  
In the state of Alabama, the incidence of and death rate for cervical cancer is 
among the highest in the United States (Miller, 2016). However, HPV vaccination in 
Alabama is currently not widely implemented in the state (Miller, 2016). It is important 
to determine a more accurate period when HPV vaccine should be administered 
particularly among teenage females. Literature about HPV vaccination and cervical 
cancer is abundant, but little research has been found about personal risk factors, factors 
affecting access to health care, and HPV vaccination in women based on demographic 
factors. The potential positive social change that could result from this study is increased 
rate and timely administration of HPV vaccination for women, which may lead to lower 
death rates (Centers for Disease Control and Prevention [CDC], 2017). In this chapter, I 
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will present information about the background for this study, purpose of this study, 
research questions, theoretical framework, nature of study, assumptions, limitations, and 
significance of this study. 
Background 
Cervical cancer is a type of cancer that affects a woman’s cervix, the lower 
portion of the uterus that connects it to the vagina (“Cervical Cancer,” n.d.). Cervical 
cancer starts in the cells lining the cervix—the lower part of the uterus (womb; American 
Cancer Society, 2018). These cancer cells grow uncontrollably, forming a tumor that may 
spread to tissues around the cervix and may even break off and end up in other parts of 
the body (Garvit, 2012). But HPV vaccine and its timely administration plays a 
significant role in controlling the incidence of cervical cancer (Petry, 2014). HPV is one 
of the most common sexually transmitted infections (Williams et al., 2015). However, 
despite the availability of vaccines to prevent HPV, the U.S. vaccination rate falls below 
the 80% national objective.  
Furthermore, previous research has reported the associations between HPV 
vaccine acceptability and parental characteristics, including sociodemographic factors, 
knowledge, perceived vaccine effectiveness, risk perceptions, and vaccine cost (Williams 
et al., 2015). Family history is beyond control when assessing the risks for cancer, but if 
the mother or sister of a patient has had cervical cancer, the likelihood of developing 
cancer increases by two to three times (American Cancer Society, 2018). Women who 
have a weak immune system due to HIV or taking immunosuppressive drugs can have a 
weaker immune system to fight off early cancer (Blake et al., 2015). Research shows that 
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patients who have chlamydia infection are at an increased risk for developing cancer of 
the cervix as well (Hirth et al., 2015). Therefore, the HPV vaccine is recommended for 
females between 13 and 60 years of age (Arbyn et al., 2015). 
This study addressed possible demographic and personal risk factors for cervical 
cancer leading to higher death rates in certain racial groups of females (Tabatbhai et al., 
2014). For example, in the state of Alabama, the death rate due to cervical cancer is 
higher in Black women as compared to White women (Miller, 2016). Research reveals 
that the incidence rate of cervical cancer is 10.1 in White females and 7.6 in Black 
females, whereas death rate due to cervical cancer is 3.4 in White females and 5.4 in 
Black females (rates are per 100,000 persons and are age-adjusted to the 2000 U.S. 
standard population)(CDC, 2017). This indicates that out of the women who are 
diagnosed with cervical cancer, approximately 71% of Black women succumb to cervical 
cancer, whereas for White women, it is only around 33%.  
Problem Statement 
Cervical cancer is the third most diagnosed cancer and the fourth leading cause of 
cancer death in females worldwide (Miller, 2016), which has disproportionately affected 
certain racial groups (CDC, 2017). In 2017, 12,820 women in the United States were 
diagnosed with cervical cancer, and 4,210 died from the disease (ASCO, 2018). The rate 
of the diagnosis of cervical cancer in Alabama is much lower than the national survey’s 
results, which could be attributed to several system barriers such as perceived lack of 
patient interest, insufficient reimbursement, and perceived parental hesitancy (Hastings et 
al., 2017).  
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In the past 40 years, the cases of cervical cancer and death rates have substantially 
subsided because of an increased number of women obtaining pap tests more frequently, 
which reveals cervical precancerous before it has extended its stage of cancer (CDC, 
2017). But research has suggested that the HPV vaccine provision in community 
pharmacies is low. Of pharmacies providing vaccinations, only 11.7% had the HPV 
vaccine in their inventory (Hastings et al., 2017). As 68.1% of pharmacists reported that 
they do not plan to offer or continue offering the vaccine in the next year. Thus, future 
research should demonstrate successful HPV vaccine services in community pharmacies 
and outline strategies to overcome system barriers and parental hesitancy (Hastings et al., 
2017). The study was conducted to address possible risk factors in reference to cervical 
cancer vaccination programs.   
Purpose of the Study 
The purpose of this study was to determine whether there was a statistically 
significant difference in the diagnosis of cervical cancer in women who received the HPV 
vaccine compared to women who did not receive the vaccine, considering demographic 
factors (race, ethnicity, level of education, household income), personal risk factors 
(sexual orientation, cigarette use, diet, and type of contraception use), and factors 
affecting access to healthcare (type of healthcare coverage, delay in receiving medical 
care). An additional purpose of this study was to determine whether there was a 
significant difference in the diagnosis of cervical cancer in women who received the HPV 
vaccine based on the number of HPV shots received and the presence sexual activity. 
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Research Questions and Hypotheses 
Research Question 1: Is there a statistically significant difference in the diagnosis 
of cervical cancer in women who received and did not receive the HPV vaccine 
considering demographic factors (race, ethnicity, level of education, household income) 
and factors affecting access to healthcare (type of healthcare coverage, delay in receiving 
medical care)? 
H01: There is no statistically significant difference in the diagnosis of cervical 
cancer in women who received and did not receive the HPV vaccine considering 
demographic factors (race, ethnicity, level of education, household income) and factors 
affecting access to healthcare (type of healthcare coverage, delay in receiving medical 
care). 
H11: There is a statistically significant difference in the diagnosis of cervical 
cancer in women who received and did not receive the HPV vaccine considering 
demographic factors (race, ethnicity, level of education, household income) and factors 
affecting access to healthcare (type of healthcare coverage, delay in receiving medical 
care). 
Research Question 2: Is there statistically significant difference in the diagnosis of 
cervical cancer in women who received and did not receive the HPV vaccine considering 




H02: There is no statistically significant difference in the diagnosis of cervical 
cancer in women who received and did not receive the HPV vaccine considering personal 
risk factors (sexual orientation, cigarette use, diet, and type of contraception use). 
H12: There is a statistically significant difference in the diagnosis of cervical 
cancer in women who received and did not receive the HPV vaccine considering personal 
risk factors (sexual orientation, cigarette use, diet, and type of contraception use). 
Research Question 3: Is there a statistically significant difference in the diagnosis 
of cervical cancer in women who received the HPV vaccine based on the number of HPV 
shots received, and the presence of sexual activity? 
H03: There is no statistically significant difference in the diagnosis of cervical 
cancer in women who received the HPV vaccine based on the number of HPV shots 
received, and the presence of sexual activity. 
H13: There is a statistically significant difference in the diagnosis of cervical 
cancer in women who received the HPV vaccine based on race, the number of HPV shots 
received, and the presence of sexual activity. 
Theoretical Framework 
The theory that guided the study was social cognitive theory. Social cognitive 
theory provides a framework for understanding, predicting, and changing human 
behavior (Ryan, 2012). The theory identifies human behavior as an interaction of 
personal factors, behavior, and the environment (Bandura, 1989). Social cognitive theory 
was helpful for understanding and predicting both individual and group behavior and 
identifying methods in which behavior can be modified or changed. The theory helped 
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explain the pattern of change in human behavior regarding administration of HPV 
vaccine during adolescence. The constructs used to measure the theory are divided into 
dependent and independent constructs. The dependent constructs are learning and change 
in behavior that would be measured in terms of incidence of cervical cancer; independent 
constructs are personal factors (initiation of sexual activity, ethnicity, and lifestyle), 
behavior (socioeconomic status), and environment (geographic location). The dependent 
constructs of the theory depend on and respond to independent constructs of the theory. 
This theory was chosen to provide an explanation incidence of cervical cancer as an 
interaction of personal factors (initiation of sexual activity), behavior (lifestyle), and 
environment (socioeconomic status; Bandura, 1989). A more detailed discussion of social 
cognitive theory will be provided in Chapter 2. 
Nature of Study 
This research study used a quantitative research methodology, which was the 
most appropriate because it emphasizes objective measurements and numerical/statistical 
data for accurate explanation of a phenomenon. This study consisted of secondary data 
analysis from the 2017 Behavioral Risk Factor Surveillance System (BRFSS). Selected 
data from females between the ages of 18 to 60 who had been diagnosed with cervical 
cancer as well as females who tested negative for cervical cancer was reviewed. The 
independent variables were race, ethnicity, level of education, household income, type of 
healthcare coverage, delay in receiving medical care, sexual orientation, cigarette use, 
diet, type of contraception use, number of HPV shots received, and the presence of sexual 
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activity. The dependent variable of the study was the diagnosis of cervical cancer. The 
data collected were analyzed using binomial logistic regression analyses. 
Definitions 
Human papillomavirus (HPV): HPV is a viral infection that is passed between 
people through skin-to-skin contact. Each HPV virus in this large group is given a 
number that is called its HPV type (CDC, 2016). There are more than 100 varieties of 
HPV, 40 of which are passed through sexual contact and can affect the genitals, mouth, 
or throat (NCI Dictionary, n.d.). 
Sexually active: Sexual activity in this study refers to sexual touching, oral sex, 
anal sex, or vaginal sex (signalhealth, n.d.). 
Socioeconomic status: Socioeconomic status is a theoretical construct 
encompassing individual, household, and/or community access to resources. It is 
commonly conceptualized as a combination of economic, social, and work status, 
measured by income or wealth, education, and occupation, respectively (Psaki et al., 
2014). 
Assumptions 
The assumptions of this research study were that participants were truthful in the 
information that they provided for dataset and that the variables that were used in this 
study were available in the dataset. It was also assumed that the sample represents the 
population and that the variables were measurable. It was also assumed that inclusion and 
exclusion criteria of the study are appropriate (Hartas, 2010). Another assumption was 
that the diagnosis of cervical cancer had been confirmed by a licensed physician. Finally, 
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the assumption was that information collected from the dataset is accurate; however, 
there is the possibility that a piece of information was not correctly recorded due to 
human error. 
Scope and Delimitations 
This study was limited to women between 18 to 60 years of age and only to 
females to make the study feasible, because I focused on the disparity between women of 
different races regarding the diagnosis and mortality rate of cervical cancer. The threats 
to validity included internal validity threats, external validity threats, construct validity 
threats, and statistical conclusion validity threats. A threat to internal validity could arise 
from the previous experiences of the participants that could influence the results. A threat 
to external validity could be that the results of the study may not be generalizable to a 
larger population of women in the United States, as the information is limited to a smaller 
sample size. Statistical conclusion validity threats might arise if the conclusion of the 
research study is influenced by the Type-I error rates during data collection. 
The theories that were considered but not used included the self-efficacy theory 
and the health belief model. The self-efficacy theory is based on the belief that some 
people have the capability to produce the effect (Bandura, 1977). That is, it addresses the 
power and ability to perform the courses of actions needed to manage situations. This 
theory was not used because it was impossible to exclude outcome considerations from 
efficacy expectations. The health belief model is based on following core beliefs based on 
perceptions, which include perceived susceptibility, perceived severity, perceived 
barriers, perceived benefits, perceived efficacy, perceived control, and perceived threat. 
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The theory also considers variables like demographic variables and predicts the 
probability of the studied individual to continue with the recommended health actions 
which may be preventive or curative by nature (Glanz et al., 2002). However, this model 
was not used as it does not account for a person’s attitudes, beliefs, or other individual 
determinants that dictate a person’s acceptance of a health behavior. 
Limitations 
The major limitation of the study was that the data collected through a 
questionnaire may have been biased and the participants may not have answered 
accurately. As I used secondary data for my analysis, I was not able to address these 
limitations. Another major limitation is the progress in the HPV vaccine over the period 
when it was administered to the selected sample and the time of the research study. The 
gap between the time of the collected data and the timing of the research study has 
witnessed technological changes that might impact the validity of the research. In order to 
address this limitation, I used the most recent available data relevant to my study. 
Significance 
The results of this quantitative study uniquely addressed the necessity for 
administration of HPV vaccine in the women regardless of their age, ethnicity, and 
economic status. The study results may enlighten individuals, the community, and society 
about cervical cancer prevention from the perspective of women who suffered from the 
disease. The potential positive social change that could result from this study is increased 
rate and timely administration of HPV vaccination for women to decrease the incidence 
of cervical cancer of women and lower the death rate due to cervical cancer. This 
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research could also promote positive social change and advance knowledge by raising 
awareness about the significance of HPV and the advantages of HPV vaccine in 
preventing cervical cancer in women. The study may encourage routine administration of 
HPV vaccine during adolescence as a professional practice in the United States to prevent 
cervical cancer. 
Summary 
This quantitative study consisted of secondary data analysis from the 2017 
BRFSS for females 18 to 60 years of age to determine whether a statistically significant 
relationship existed between demographic and personal risk factors, HPV vaccination, 
and cervical cancer throughout the United States. In Chapter 2, I provide my literature 
search strategy, theoretical framework, and provide an overview of the current literature 





Chapter 2: Literature Review 
The prevalence and rise in the new cases of cervical cancer is witnessed in the 
developing areas (Petry, 2014), and the rate of cervical cancer has increased worldwide 
despite vaccine availability (Guglielmo et al., 2014). The purpose of this study was to 
determine whether there was a statistically significant difference in the diagnosis of 
cervical cancer between women who did and did not receive the HPV vaccine based on 
demographic factors (race, ethnicity, level of education, household income), personal risk 
factors (sexual orientation, cigarette use, diet, and type of contraception use), and factors 
affecting access to healthcare (type of healthcare coverage, delay in receiving medical 
care). I also examined whether there was a significant difference in the diagnosis of 
cervical cancer in women who received the HPV vaccine based on the number of HPV 
shots received and the presence or absence of sexual activity. 
Chapter 2 will present information about the literature search strategy, the 
theoretical framework, and a review of the literature related to cervical cancer, the HPV 
vaccine, the incidence rate and death rate among women due to cervical cancer, the 
factors associated with cervical cancer, and the preventive measures required to control 
morbidity and mortality rates of cervical cancer as well as previous similar studies and 
methodology used. 
Literature Search Strategy 
Literature was searched using Google along with the Walden Library Health 
Sciences Research databases. Information was retrieved by searching through PubMed, 
ProQuest, Google Scholar, Science Direct, and included peer reviewed journals, 
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encyclopedias, scholarly articles, and books. The search terms that were used included 
cervical cancer and HPV, HPV vaccine, cervical cancer incidence in Alabama, death 
rate in Alabama, HPV vaccine benefits and effectiveness, cervical cancer in teenage 
girls, resistance towards HPV vaccine, socioeconomic status and cervical cancer, 
cervical cancer and ethnicity, social cognitive theory, quantitative research methodology, 
binomial logistic regression, G-Power, and sample size. 
The literature was searched from the year 2009 to current year. Every keyword 
searched resulted in 150 to 200 results. All articles were peer reviewed. However, not all 
the articles retrieved by the search were full text. For some of the articles, only the 
abstract was available, but only full-text articles were used for the literature review. The 
numbers for full-text articles after narrowing the inquiry reduced considerably. The 
numbers of results also declined considerably when researched using Google Scholar. 
The reference list of the articles and research studies selected provided additional 
articles and resources. Several sources and the information from the Health Information 
National Trends Survey was also relied on and included as per the relevance to my topic. 
Some sources that provided significant information from older publications were also 
included. Several journals exclusively for women’s health and related to cancer were 
included as they provided unique and significant information. The magazines and opinion 
surveys available through Google were also considered for obtaining more relevant 




The social cognitive theory served as the theoretical framework for this research. 
The theory originated from Albert Bandura (Bandura, 1989). The unique feature of the 
social cognitive theory is the emphasis on social influence and its emphasis on external 
and internal social reinforcement (Bandura, 1989). This theory takes into consideration 
the unique way in which individuals acquire and maintain behavior while also 
considering the social environment in which individuals perform the behavior (LaMorte, 
2016). The theory also considers a person’s past experiences which factor into whether 
behavioral action will occur (Ryan, 2012). These past experiences influence 
reinforcements, expectations, and expectancies, all which shape whether a person will 
engage in a specific behavior and the reasons why a person engages in that behavior 
(LaMorte, 2016). For example, social cognitive theory can help explain how people adapt 
healthier habits and reduce unhealthy habits (Bandura, 2004, p. 146).  
The purpose of social cognitive theory is to explain how people regulate their 
behavior through control and reinforcement to achieve goal-directed behavior that can be 
maintained over time (LaMorte, 2016). The theory identifies human behavior as an 
interaction of personal factors, behavior, and the environment (Bandura, 1989). The six 
constructs of the social cognitive theory are reciprocal determinism, behavioral 
capability, observational learning, reinforcements, expectations, and self-efficacy 
(Bandura, 1989). Reciprocal determinism refers to the dynamic and reciprocal interaction 
of person (individual with a set of learned experiences), environment (external social 
context), and behavior (responses to stimuli to achieve goals) (Bandura, 1989). Thus, all 
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three factors—environment, behavior, and personal factors—interact and influence each 
other. This construct relates to my study as the change in behavior (i.e., the dependent 
variable incidence of cervical cancer) could be observed based on the environment (i.e., 
the independent variable administration of HPV vaccine) as well as personal factors (i.e., 
the covariates of race, ethnicity, socioeconomic status). 
Behavioral capability refers to a person’s actual ability to perform a behavior 
through essential knowledge and skills (Bandura, 1989). This construct requires 
providing adequate knowledge and skills for desirable behavioral changes. This construct 
relates to my study as knowledge and skill (i.e., awareness and accessibility of HPV 
vaccine) would result in change of behavior (i.e., more people opting for HPV 
vaccination). 
Observational learning asserts that people can witness and observe a behavior 
conducted by others and then reproduce those actions (Bandura, 1989). For example, 
witnessing the benefits of HPV vaccination can lead to more receiving the vaccine. 
Similarly, reinforcements refer to the internal or external responses to a person’s behavior 
that affect the likelihood of continuing or discontinuing the behavior (Bandura, 1989). 
This construct is applicable to the people in helping them continue with the behavior 
(dosages of HPV vaccination) based on their internal and external responses.  
Expectations refer to the anticipated consequences of a person’s behavior. 
Outcome expectations can be health-related or not health-related. People anticipate the 
consequences of their actions before engaging in the behavior, and these anticipated 
consequences can influence successful completion of the behavior (Bandura. 1989). Here 
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expectation refers to the successful prevention from cervical cancer before engaging in 
the behavior (administration of HPV vaccine). 
Finally, self-efficacy refers to the level of a person’s confidence in his or her 
ability to successfully perform a behavior (Bandura, 1989). This construct refers to the 
mental strength of the individuals before they engage in a behavior (e.g., HPV 
vaccination). Social cognitive theory is helpful for understanding and predicting both 
individual and group behavior and identifying methods in which behavior can be 
modified or changed. This theory can help in understanding the pattern of change in 
human behavior regarding administration of HPV vaccine during adolescence. This 
theory is the most appropriate for my research study because it helped identify the 
incidence of cervical cancer as an interaction of personal factors (initiation of sexual 
activity), behavior (lifestyle), and environment (geographic location, socioeconomic 
status). 
In previous research, social cognitive theory has been used to explain health 
behavior like exercise as well as self-management of chronic disease. Allen (2004) 
examined the literature on diabetes research using social cognitive theory to determine its 
predictive ability in explaining exercise behavior and to identify key interventions that 
enhance exercise initiation and maintenance. In correlational studies, a significant 
relationship was found between self-efficacy and exercise behavior. The predictive 
ability of outcome expectancies for exercise behavior demonstrated mixed results. 




Additionally, Sell et al. (2006) reviewed literature and demonstrated several gaps 
in the literature regarding use of social support in self-management, impact of moral 
disengagement, and studies specifically targeting older adults. The integrative review 
explicated two areas related to the theory in need of further research. First, social support 
has not been thoroughly explored as a mechanism for enhancing self-management 
interventions. Second, moral disengagement was not identified as a focus within chronic 
disease research raising the question about the impact of moral disengagement on long-
term adherence and behavior change. 
Literature Review Related to Key Concepts 
Cervical Cancer Overview 
Cervical cancer is a type of cancer that affects a woman’s cervix, which is mainly 
caused by HPV, a sexually transmitted disease transferred through intercourse with 
someone that has been previously affected (“Cervical Cancer,” n.d.). Because it is 
acquired through sex, it is mostly contracted around the time of sexual maturity when a 
female’s immune system defenses are at their lowest. When infected, a woman’s immune 
system in some cases can fight off the disease and stop it before it develops into cervical 
cancer (Gravitt, 2012). But in 60% of cases, a woman cannot fight off the disease and 
cervical cancer precursor lesions are formed (Gravitt, 2012). These lesions cause some of 
the affected epithelial cells on the woman’s uterus to transform into cancer cells and then 
a tumor, which may spread to tissues around the cervix and may even break off and end 
up in other parts of the body (“Cervical Cancer,” n.d.). 
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Early cervical cancer has no manifestation in women and can go unnoticed until it 
is too late. But when the disease progresses far enough, there are a few signs that women 
should be aware of to recognize cervical cancer (Gravitt, 2012). One of the signs is blood 
or discharge from the vagina during or after sex, between menstrual cycles, or after 
menopause. This discharge may be thick, watery, and have a distinguishable foul odor. 
Another sign is experiencing pain in the pelvic region during intercourse (“Cervical 
Cancer,” n.d.). These signs should be noted and followed up by a health care 
professional. 
The controllable risk factors associated with cervical cancer also need to be made 
clear to patients to decrease the odds of getting the disease. Smoking can cause a person 
to be two times more likely of getting cervical cancer (Gravitt, 2012). The chemicals that 
come from smoking are carried throughout the bloodstream and can be found in the 
cervical mucus of those who smoke, and smoking causes the immune system to become 
less effective in fighting off HPV. A diet with low amounts of fruits and vegetables and 
being overweight can also increase the probability of developing cancer of the cervix 
(Gravitt, 2012). 
Family history is out of the control of anyone looking at the risks for cancer, but if 
the mother or sister of a patient has had cervical cancer, the likelihood of developing 
cancer increases by two to three times (American Cancer Society, 2018). The daughters 
of a mother who took diethylstilbestrol during pregnancy to prevent a miscarriage are at 
an increased risk for cancer of the cervix. Another medication that can increase the risk 
includes birth control pills. The long-term use of birth control pills places a patient at an 
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increased risk during use, but when the medication is stopped, the risk goes back to 
before the use began.  
Other factors that increase risk of cervical cancer are related to pregnancy, having 
a weak immune system or chlamydia, taking birth control, and level of income. Having 
three or more full term pregnancies places a woman at a higher risk for cancer. 
Additionally, a full-term pregnancy at an age younger than 17 years old increases the risk 
for cervical cancer to two times more likely when compared to women who waited until 
25 years old or order to have children (Blake et al., 2015). Further, women who have a 
weak immune system due to HIV or taking immunosuppressive drugs can cause the body 
to have a weaker immune system to fight off early cancer (Blake et al., 2015). Research 
also shows that patients who have chlamydia infection are at an increased risk for 
developing cervical cancer, which they might not be aware of until a pap smear (Hirth et 
al., 2015). Gynecologists have also reported that low-income individuals are at more risk 
for having cancer due to not being able to early detect some of the risk factors (Wong & 
Do, 2012). Teaching patients the risk factors for cervical cancer allows them to change 
the things that can be altered and be aware of the factors that cannot be changed to make 
sure they get examined regularly for cancer of the cervix.  
Further, research has revealed that Black women in the United States are dying 
from cervical cancer at a rate 77% higher than previously thought, whereas White women 
are dying at a rate 47% higher (Cancer Vaccine Week, 2017). Alabama has the highest 
cervical cancer death rate in the United States, and Black women are almost twice as 
likely to die of the disease as White women (roughly 5.2 Black women for every 2.7 
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White women). This disparity is significant because cervical cancer is preventable and 
treatable with adequate gynecological care and early screenings, which generally lead to 
a 93% 5-year survival rate. But delayed treatment worsens those chances, and across the 
Black Belt, institutionalized racism leaves women neglected by the state’s crumbling 
social infrastructure (Chen, 2018). In Alabama, women are dying from the disease at 
rates that are higher than in any other state in the United States. Nationwide, Black 
women are more likely to die from this disease than women from any other racial or 
ethnic group (Chen, 2018). 
Cervical cancer can be prevented to a significant extent if screening is done 
proactively (Guglielmo et al., 2014). The HPV vaccine and its timely administration also 
play a significant role in controlling the incidence of cervical cancer (Petry, 2014). But 
there is a link between the attitude toward cervical cancer prevention and the 
abnormalities caused by cervical cancer. There was an examination done to verify 
whether women with a history of cervical abnormalities expect reactions to cervical 
cancer. The measurement was related to the proficiencies of cervical abnormalities that 
elaborate politics, outlooks, and actions that are associated with cervical cancer 
prevention. The report showed that these women were more positive of observations of 
pap testing and HPV vaccination than women who had obtained normal pap testing 
results (The Association Between Cervical Abnormalites and Attitudes Toward Cervial 
Cancer Prevention, n.d.). Pap tests were perceived as being more effective at reducing the 
chance of developing cervical cancer in women if vaccination took place. Intent to 
vaccinate their daughters against HPV were highest among women who had cervical 
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cancer, women who had hysterectomies, and women who were treated for precancerous 
lesions (each p < 0.05). That is, HPV vaccination was favored by the women who had 
already suffered cervical cancer abnormalities compared to healthy women. 
In terms of prevention, research has also evaluated the efficiency of HPV 
vaccines. Two distinct vaccines were evaluated, Gardasil a quadrivalent vaccine 
containing virus-like particles of types 6, 11, 16 and 18 and Cervarix, a bivalent vaccine 
containing virus-like particles of types 16 and 18 (Schiller et al., 2012). Both vaccines 
exhibited excellent safety and immunogenicity profiles. The vaccines also demonstrated 
remarkably high and similar efficacy against the vaccine-targeted types for a range of 
cervical endpoints from persistent infection to cervical intraepithelial neoplasia grade 3 
(CIN3) in women naïve to the corresponding type at the time of vaccination. However, 
protection from incident infection or disease from non-vaccine types was restricted, and 
the vaccines had no effect on prevalent infection or disease. 
Sociocultural Factors and Cervical Cancer 
Cervical cancer offers an example of how sociocultural factors such as gender, 
ethnicity/race, class, and attitudes toward sexuality converge to shape the risk and 
experience of cancer among women. 
Race and Ethnicity 
Race refers to the categorization of human beings into several groups based on 
their physical traits, ethnicity, or genetics such as color of skin (Templeton, 2013). 
Analyzed trends in imposing cervical cancer prevalence in relation to 35-year period 
reveals that the death rate due to cervical cancer is higher among Black women as 
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compared to White women in Alabama though the incidence rate of cervical cancer is 
higher in White women (Cervical cancer overview, 2012). Perceived susceptibility to 
cervical cancer in Hispanic women seems to be influenced more importantly by the 
current or past perception of HPV/STI exposure, and by having a relative with cancer 
(Garcés-Palacio & Scarinci, 2012). 
A gap was identified about the awareness and knowledge of HPV and HPV 
vaccine by race and ethnicity (Blake et al., 2015). Women living in rural areas and of 
lower socioeconomic status lead in cervical cancer mortality rate as compared to the 
women from urban areas. Further, the death rate due to cervical cancer is higher among 
Black and Hispanic women as compared to non-Hispanic White women. The gap existed 
not only in awareness and in knowledge about HPV and HPV vaccine, but also in obesity 
level and cancer screenings (Jacqueline et al., 2015). 
The evaluation of 4,992 women for Pap testing suggested that White women with 
a higher household income reported a Pap test with 95% confidence interval as compared 
to Black women and other White women with lower household income (Jacqueline et al., 
2015). Research also suggested that insurance coverage also played a crucial role for 
cancer screenings for both Black and White women (Madadi et al., 2014). Research has 
shown that less than 64.1 percent of low-income populations, specifically African 
American and Hispanic women, undergo cervical cancer screenings (Hirth et al., 2015). 
This leads to a higher incidence rate of HPV in these specific populations. Data suggested 
that 11.5 percent of African American and 14.2 percent of Hispanic women have a 
diagnosis of cervical cancer (Hirth et al., 2015). This value is greatly elevated from 8.8 
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percent of the general population (Hirth et al., 2015). Some of the suspected factors for 
this data include socioeconomic factors, lack of a stable form of healthcare, being 
uninsured, not feeling that they are at risk for cervical cancer, and different beliefs 
regarding the occurrence and treatment of cancer (Ackerson & Gretebeck, 2007). 
Socioeconomic Status 
Socioeconomic status is the social standing or class of an individual or group (Lai 
et al., 2013). It is often measured as a combination of education, income and occupation. 
The awareness about the HPV vaccine and its administration depends upon the education 
and income of the individual (Ramirez et al., 2013). Socioeconomic status could be a 
barrier in prevention of cervical cancer as the awareness about the adequate measures of 
vaccination is not provided in the ethnic group. The most important aspect being 
education as it impacts the awareness as well as understanding of the people regarding 
the vaccination (D’Orazio et al., 2014). 
Women living in rural areas and of lower socioeconomic status lead in cervical 
cancer mortality rate as compared to the women from urban areas (Kontos et al., 2012). 
Further, the death rate due to cervical cancer is higher among African American and 
Hispanic women as compared to non-Hispanic White women (Kontos et al., 2012). 
Socioeconomic status influences education level as well as the capacity to seek insurance 
coverage. Women with lower socioeconomic status tend to receive lower level of 
education and have lower insurance coverage, which in turn, results in lack of cancer 
screenings and vaccination (Kontos et al., 2012). The U.S. Census Bureau reports an 
increased poverty rate of approximately 25 percent among African American and 
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Hispanic individuals (Semega et al., 2017). This far exceeds the 8.6 percent poverty rate 
for non-Hispanic White individuals (Semega et al., 2017). For the 41 percent of this 
population that is uninsured, the costs of cervical cancer screenings may not be affordable 
for them (Semega et al., 2017). 
Along with the cost burden, many women in this population have misconceptions 
about what the diagnosis of cervical cancer could mean to them (Ramirez et al., 2013). 
When asked what they believe about cancer, Hispanic and African American women 
responded with saying that “cutting into cancer can make it spread,” that “the treatment 
of cancer is worse that the disease,” and that “there is very little a person can do to reduce 
their risk of cancer”. Others also stated that if they are not participating in “risk-taking 
sexual activities” than there is no need to get screened (Ramirez et al., 2013). 
Research indicated that the most basic reason these women chose not to get 
screened is because their healthcare provider did not explicitly recommend it to them 
(Ackerson & Gretebeck, 2007). This highlights the necessity for the medical personnel to 
reach into these communities and provide patient teaching as well and encouragement to 
get screened. 
Location of Residence 
Geography influences the incidence of cervical cancer based on the awareness 
and availability of the vaccines in the region (Anhang et al., 2011). It is realized that 
women in rural areas exhibit higher mortality rates due to cervical cancer as compared to 
the women living in urban areas. This is also because women in rural areas have low 
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accessibility of information and knowledge about HPV vaccine and associated cervical 
cancer (Anhang et al., 2011). 
Sexual Lifestyle 
Sexual lifestyle refers to the initiation of sexual activity, number of sexual 
partners, and the usage of contraceptives (Finer & Phiblin, 2013). These all influence the 
incidence of cervical cancer among women. Initiation of sexual activity at a very early 
age increases the risk of HPV infection (Finer & Phiblin, 2013). In addition, unprotected 
sex with multiple partners increases the possibility of HPV infection (Finer & Phiblin, 
2013). The usage of contraceptive pills for longer duration also increases the possibility 
of HPV infection among the females (Ramirez et al., 2013). 
Attitude Toward Vaccination 
Vaccination is a recognized tool by the medical community for prevention of 
particular diseases and for promotion of public health. However, there are individuals 
who doubt the benefits and the needs of the vaccination; and consciously decide not to be 
vaccinated. This practice of discarding vaccination is also termed as vaccine hesitancy, 
which soon is transformed into vaccine refusal (Arbyn et al., 2015)). Hesitancy is not 
clear rejection, but the resistance towards vaccination which later combine with lack of 
awareness about vaccine benefits results in a decision to not get vaccinated. 
The attitude towards vaccination, in general, largely depends upon awareness 
about the vaccine benefits. The attitude of ‘hesitancy’ can be changed towards desire of 
being vaccinated by adequate communication between the target population and the 
providers of the vaccine. The attitude towards vaccine is also impacted with experiences 
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of kith and kin (Arbyn et al., 2015). That is, ‘hesitancy’ changes to rejection if vaccine 
goes ineffective for anyone in the family or friends. 
The acceptance of HPV vaccination for teenage girls also depends upon parental 
beliefs about cancer and their trust in health information. It was found that parents were 
more likely to accept the vaccine if they perceived a higher risk of getting cancer 
themselves and if they had a higher level of trust in health information from medical 
authorities. Perceived severity of cancer and fatalistic beliefs about cancer prevention did 
not predict vaccine acceptance (Nan et al., 2014). It is vital that parents understand the 
benefits of HPV vaccine and accept the same for their daughters well in time in order to 
reap the best benefits and enhanced effectiveness of the vaccination against fatal cervical 
cancer. 
Research suggests, however, that many women do not regularly attend routine 
cervical screenings due to both knowledge deficit, as well as fear of results; as many as 
38% of women are not seeking cervical screenings due to the latter reasoning (Petry, 
2014). This is a big concern to many medical professionals because detection time and 
survival rate are very positively correlated. A key role of nursing care is to reduce this 
anxiety and fear by providing support and care for each patient as needed (Nan et al., 
2014). 
In addition to keeping women informed and at ease, education regarding cervical 
cancer and HPV vaccination should be provided to both genders on the importance of 
sexual health and particularly, wearing condoms during intercourse (Blake et al., 2015). 
HPV infection has been recognized as the main risk factor in the development of cancer. 
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Condoms can reduce the rates of HPV infections along with immunizing young females 
(Blake et al., 2015). 
Cervical Cancer Screening and Treatment 
HPV is a highly prevalent, sexually transmitted infection that causes cervical 
cancer and contributes towards increasing rates of mortality and morbidity. HPV is 
primarily responsible for both high grade and low-grade cervical lesions. HPV types that 
are the most common HPV types found in cervical cancer are HPV 16 and 18 and are 
responsible for approximately 70% of these cancers (Petry, 2014). On the other hand, 
low-risk HPV types, the most common of which are HPV 6 and 11, cause genital warts, 
low-grade cervical lesions, and recurrent respiratory papillomatosis, but they do not cause 
cervical or other HPV-related cancers (Guglielmo et al., 2014). 
The most common way that cervical cancer is found is through a Pap smear 
performed by a gynecologist or other healthcare professional (Ashok et al., 2012). 
However, there is a possibility of a false positive and false negative result for a Pap smear 
test. A false-positive test result indicates that one has a high-risk type of HPV when one 
really does not. A false-negative test result means one really does have an HPV infection, 
but the test indicates that one does not have any infection (Mayo Clinic, 2018). The 
problem of false positives and false negatives can be minimized by avoiding intercourse, 
douching, or using any vaginal medicines or spermicidal foams, creams, or jellies for two 
days before the test (Reboji et al., 2013). 
According to the American Cancer Society (2012), women should begin cervical 
cancer screenings when they turn 21 or 3 years after beginning sexual intercourse, 
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whichever comes first. This is to detect any changes that occur during the early disease 
process. After age 30, women can begin having pap smears every 3 years and they can be 
discontinued altogether after the age of 70 if the screenings have been normal for the last 
10 years. These guidelines do not seem to be commonly adhered to according to the 
CDC’s research that 60% of women diagnosed with cancer have never gotten a pap 
smear before or have not had one in 5 years (Arbyn et al., 2015). In the case of abnormal 
cells, being found from the Pap smear another test will be done that is called a 
colposcopy (Ashok et al., 2012). 
A colposcopy involves the use of a colposcopy, which is a magnifying lens device 
that is used on the outside of the cervix to see it clearly (Ashok et al., 2012). After 
looking through the colposcopy, a biopsy may need to be performed to further examine 
abnormal cells in the cervix. A biopsy is a procedure where some tissue from the cervix 
is removed for further testing. Biopsies are done to be certain if what looks to be 
abnormal is indeed cancer. In addition, a cystoscopy, proctoscopy, and an exam under 
anesthesia may be done through the insertion of a lighted tube to view other regions of 
the systems to see where the cancer has spread (Ashok et al., 2012). 
There are many methods to screening a patient that has been suspected to have 
cancer of the cervix. Treatment options can then be determined through the patient and 
healthcare physician working together to develop a plan of action to fight the cancer. 
Considering pre-cancers and invasive cancers, cryosurgery or laser surgery may be the 
treatment chosen. Cryosurgery involves a metal probe that has been cooled with liquid 
nitrogen to be placed in vagina and cervix to freeze any of the abnormal cells (Miller, 
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2016). Laser surgery is also performed by burning off pre-cancers and removing small 
pieces of tissue for biopsy (Ramirez et al., 2013). 
Cervical cancer that has reached stage I, can be treated, or found using a 
technique called conization (D’Orazio et al., 2014). Conization involves the removal of a 
cone shaped piece of tissue from the cervix using a surgical or laser knife (D’Orazio et 
al., 2014). This is the procedure of choice for women who still want to have children. In 
stage I or II of cervical cancer a hysterectomy may be performed (D’Orazio et al., 2014). 
A hysterectomy can be radical or simple, depending on the patient’s specific cancer 
(D’Orazio et al., 2014). 
A simple hysterectomy includes the removal of the cervix and uterus, while a 
radical hysterectomy removes more than the simple hysterectomy (D’Orazio et al., 2014). 
It also removes the tissues next to the uterus and the upper part of the vagina next to the 
cervix. A radical hysterectomy can include the removal of the ovaries, fallopian tubes, 
and lymph nodes as well. A radical hysterectomy is performed more in early-stage II 
cancers (D’Orazio et al., 2014). A trachelectomy is a procedure done in the treatment of 
cervical cancer but is a method that allows young women to still can give birth. The 
uterus is left behind during this surgery and the cervix and upper part of vagina are 
removed (D’Orazio et al., 2014). 
The risks associated with cancer coming back in this procedure are low but 
creates a higher risk for miscarriages than seen in healthy women (Hawkins et al., 2010). 
Another treatment option for the more severe cases of cervical cancer involves the use of 
radiation or chemotherapy treatments. Radiation therapy is used to kill any cancer cells 
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and hopes to shrink any tumors (Ramirez et al., 2013). Radiation is a medical care that 
uses high-energy rays like an x-ray to kill the cancer cells. Radiation for cervical cancer 
is almost always used alongside with chemotherapy drugs. The chemotherapy drugs that 
a doctor prescribes can be taken PO or through an IV, and once in the bloodstream it will 
circulate throughout the body (Blake et al., 2015). 
Chemotherapy and radiation given together can improve the chances of survival 
for the patient (Blake et al., 2015). Medical care can help and may also cure cases of 
cervical cancer. However, it is always better to prevent the incidence of cervical cancer 
and HPV infection. In the context of cervical cancer, it is important that nurses 
consistently educate their patients, particularly by promoting cervical screenings and 
encouraging young women to receive HPV vaccinations (Petry, 2014). 
HPV Vaccination 
HPV infection is most common in young, sexually active populations, and it is 
estimated that three fourths of adults will be infected with HPV during their lifetime 
(Guglielmo et al., 2014). To control cervical cancer morbidity and mortality rates, it is 
paramount that awareness and knowledge about HPV and HPV vaccine should increase. 
The increased knowledge of benefits of HPV vaccination should also be able to transform 
into willingness to accept the vaccination. The suboptimal acceptance of HPV 
vaccination is a worrying cause of concern (Deanna et al., 2012). Earlier, there was no 
effective vaccine to reduce the risk of HPV acquisition. Now, two types of HPV 
vaccines- quadrivalent and bivalent are available to protect against both high-risk and 
low-risk HPV infections (Guglielmo et al., 2014). The vaccination against HPV is 
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promising and can reduce HPV-associated morbidity and mortality, if adequately 
implemented. 
It is important to study cervical cancer diagnosis and to determine the accurate 
time when HPV vaccine should be administered among teenage females in order to 
enhance the effectiveness of HPV vaccine. Preventive measures are needed and therefore, 
HPV vaccine is recommended for females between 13 and 60 years of age (Blake et al., 
2015). The acceptance of HPV vaccine is impacted by several factors. Research indicates 
Lai et. al (2013) found that HPV knowledge level was high among US women, but it was 
not associated with the willingness to vaccinate their daughters against HPV. Further, it 
was also found that the white women displayed higher willingness to accept HPV 
vaccination as compared to Black women. 
An increased vaccination rate for HPV could result in reduction of HPV infection 
and incidence of cervical cancer (Jacqueline et al., 2015). There are two vaccines for 
HPV, Gardasil and Cervarix (Ortiz et al., 2012). These vaccines tend to prevent 
infections by high-risk HPV types, which cause most cervical cancers (Ortiz et al., 2012). 
Gardasil was approved in 2006, and protects against HPV types 6, 11, 16, and 18; 
Cervarix was approved in 2009, and protects against HPV types 16 and 18 (Ortiz et al., 
2012). It is important for the HPV vaccination to be administered and all 3 doses are 
completed on time for the vaccine to be effective (Ortiz et al., 2012). 
Timing of Vaccination, Adolescence vs Post Adolescence 
The timing of HPV vaccination is crucial in prevention of the incidence of 
cervical cancer. Optimally, the HPV vaccine should be administered before sexual 
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initiation (Deanna et al., 2012). The systematic review and meta-analysis to evaluate the 
efficacy and safety of HPV vaccines in preventing cervical intraepithelial neoplasia 
grades 2 and 3 (CIN2 and CIN3), adenocarcinoma in situ (CIN2+) and cervical cancer 
suggested that the vaccines currently available are effective, safe, and capable of 
preventing CIN2+ lesions (Rey-Ares et al., 2012). The public health benefits of the 
vaccine and cost effectiveness have been validated in multiple studies (White, 2014). For 
female patients, the cervical cancer prevention with vaccine administration remains 
superior to cervical cancer screening programs employing Papanicolaou smears alone 
(Holman et al., 2014). 
The CDC recommended schedule is for routine HPV vaccination at ages 11 and 
12, with catch-up vaccination up to age 26 for females (Markowitz et al., 2014). 
Guidelines recommend that age-eligible women with past exposure to HPV should still 
be vaccinated. Little is known about how primary care providers (PCPs) use sexual 
history and HPV and Pap tests in their HPV vaccine recommendations (Deanna et al., 
2012). A healthcare provider’s recommendation is the strongest known predictor of 
initiation and completion the 3-dose HPV vaccine series (Dorell et al., 2012, Kessels et 
al., 2012). 
Availability and Accessibility to Vaccination 
This is a major concern as the availability and accessibility of HPV vaccination is 
important to control the incidence of cervical cancer. This depends upon the geographical 
location and socioeconomic status of the people (D’Orazio et al., 2014). It is important to 
create high level awareness about the benefits of the vaccination and to make it available 
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and accessible for every woman. The rate of contraction has increased despite vaccine 
availability (Jacqueline et al., 2015). 
Research reveals that a huge gap exists about awareness and knowledge about 
HPV vaccine by sex, education, income, race/ethnicity, geographic area, and other 
important sociodemographic characteristics (Blake et al., 2015). This gap in awareness 
also leads to the difference in mortality and morbidity rates caused due to HPV infection.  
Women living in rural areas and of lower socioeconomic status lead in cervical cancer 
mortality rate as compared to the women from urban areas (Ramirez et al., 2013). 
Further, the death rate due to cervical cancer is higher among African American and 
Hispanic women as compared to non-Hispanic White women (Ramirez et al., 2013). 
Previous Studies and Methodology Used 
Jassim et al. (2018) explored the knowledge, attitudes, and practices of women 
attending primary care health centers for cervical cancer screening among women 
visiting primary health care centers in Bahrain. In this cross-sectional quantitative study, 
300 women were taken as a sample. A validated tool comprised of 45 items to collect 
data through face-to-face interviews between December 2015 and February 2016. The 
participants demonstrated a wide range of knowledge and attitudes towards cervical 
cancer screening. However, the majority demonstrated positive attitudes towards the 
HPV vaccine (Jassim et al., 2018). 
Assoumou et al. (2015) conducted a quantitative study to assess the awareness 
and knowledge about cervical cancer, Pap smear testing and its use and HPV among 
women living in Libreville, Gabon. A total of 452 women aged 16 years and older were 
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recruited from different town locations. Logistic regression analysis was used to identify 
the effect of demographic characteristics on the level of knowledge about cervical cancer, 
Pap smear testing and HPV. Odds ratio and 95% confidence intervals were used to 
identify the strength of association. This study demonstrates a very low level of 
knowledge about cervical cancer, Pap smear testing and HPV in a sample of Gabonese 
women. There is a critical need for Gabonese women to be informed about cervical 
cancer and the Pap smear test to improve the use of this preventive method (Assoumou et 
al., 2015). 
Daley et al. (2013) initiated a quantitative study to examine Pap smear knowledge 
among three high-risk populations at different points in time. The study employed 
frequencies and logistic regression to examine associations between demographic factors 
and accurate knowledge of Pap smear testing within three separate HPV psychosocial 
studies. The three studies were conducted - (1) HPV-positive women (prevaccine 
population in 2005-2006, n = 154, mean age 23.5), (2) college women (postvaccine 
population in 2008, n = 276, mean age 18.9), and (3) minority college women 
(postvaccine population in 2011, n = 711, mean age 23.3) (Daley et al., 2013). 
Knowledge about the purpose of the Pap smear remains low. Findings underscore the 
significant need for clear and consistent messages among high-risk women regarding the 
prevention of cervical cancer and other reproductive health conditions (Daley et al., 
2013). 
Al-Shaikh et al. (2014) assessed the level of knowledge regarding cervical cancer 
and the acceptance of the human papilloma virus (HPV) vaccine among Saudi female 
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students in health colleges through a study. Approximately 1400 students from Health 
Colleges at Princess Nora Bint Abdul Rahman University, Riyadh, Saudi Arabia were 
conveniently selected as a sample for cross-sectional quantitative study. A self-
administrated questionnaire was distributed to all participants. Data collected included 
socio-demographic data, knowledge of cervical cancer risk factors and clinical 
presentation, Pap smear, and HPV vaccine acceptance. Vaccine acceptance is influenced 
by its price; approximately 80% of students thought that an affordable vaccine price 
should not exceed 300 Saudi Riyals. Perceived barriers to the vaccine were fear of 
injections and vaccine side effects (Al-Shaikh et al., 2014). A lack of knowledge and 
misinformation exists regarding cervical cancer, Pap smear, and HPV as a major risk 
factor for cancer of the cervix. 
Summary and Conclusion 
Research indicates that there is a difference in the awareness and knowledge 
about HPV vaccine by sex, education, income, race/ethnicity, geographic area, and other 
sociodemographic characteristics. It is important to target populations that are still 
unaware about the benefits of HPV vaccine. Women of lower socioeconomic status and 
of races such as African American, Hispanic, and Black.  need adequate knowledge about 
HPV vaccine and associated cervical cancer morbidity and mortality. Women living in 
rural areas and of lower socioeconomic status lead the cervical cancer mortality rate as 
compared to the women from urban areas. Further, the death rate due to cervical cancer is 
higher among African American and Hispanic women as compared to non-Hispanic 
White women. The race, level of household income, education, as well as insurance 
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coverage impacts the vaccination and cancer screenings among women. HPV vaccine is 
effective if it is administered at an early age before a woman is infected with the virus. 
However, if the vaccine is administered after the woman is already infected, then it would 
not result in positive effect. In addition, there are several types of HPV vaccines and they 
need to be administered taking other parameters of the women in consideration. Providers 
may also be recommending the vaccine to women who may receive little benefit from the 
vaccine. Provider and system-level efforts to improve guideline-consistent practices are 
needed. Chapter 3 will provide description of the research methods that will be used to 





Chapter 3: Research Method 
The purpose of this study was to determine whether there was statistically 
significant difference in the diagnosis of cervical cancer in women who received the HPV 
vaccine compared to women who did not receive the vaccine, considering demographic 
factors (race, ethnicity, county of residence, level of education, household income), 
personal risk factors (sexual orientation, cigarette use, diet, and type of contraception 
use), and factors affecting access to healthcare (type of healthcare coverage, delay in 
receiving medical care). An additional purpose of this study was to determine whether 
there was a significant difference in the diagnosis of cervical cancer in women who 
received the HPV vaccine based on the number of HPV shots received and the presence 
or absence of sexual activity. Chapter 3 includes information about the research design, 
methodology, data collection, data analysis, threats to validity, and ethical considerations 
for this study. 
Research Design and Rationale 
A quasi-experimental (non-equivalent group design) for this quantitative study 
was selected because it allowed me to assign numerical values to the variables and 
manipulate and analyze a larger dataset.  Additionally, it helped me to draw cause–effect 
inferences. These designs often use intact groups that are similar to an extent so that they 
are fairly compared, though the groups may not be comparable, and it is unlikely that the 
two groups are similar if they were assigned through a random lottery (The Use and 
Interpretation of Quasi-Experimental Studies in Medical Informatics, n.d.)Because it is 
often likely that the groups are not equivalent (as in this study), there are two groups that 
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are similar in several ways but are non-equivalent, which allows fair comparison between 
the two groups. There were no anticipated time or resource constraints in the conduct of 
this study. 
For this study, the independent variables were race, ethnicity, county of residence, 
level of education, household income, type of healthcare coverage, delay in receiving 
medical care, sexual orientation, cigarette use, diet, type of contraception use, vaccine 
administration, number of HPV shots received, and the presence of sexual activity. The 
dependent variable of the study was the diagnosis of HPV. The research questions and 
hypotheses for this study are: 
Research Question 1: Is there a statistically significant difference in the diagnosis 
of cervical cancer in women who received and did not receive the HPV vaccine 
considering demographic factors (race, ethnicity, level of education, household income) 
and factors affecting access to healthcare (type of healthcare coverage, delay in receiving 
medical care)? 
H01: There is no statistically significant difference in the diagnosis of cervical 
cancer in women who received and did not receive the HPV vaccine considering 
demographic factors (race, ethnicity, level of education, household income) and factors 
affecting access to healthcare (type of healthcare coverage, delay in receiving medical 
care). 
H11: There is a statistically significant difference in the diagnosis of cervical 
cancer in women who received and did not receive the HPV vaccine considering 
demographic factors (race, ethnicity, level of education, household income) and factors 
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affecting access to healthcare (type of healthcare coverage, delay in receiving medical 
care). 
Research Question 2: Is there a statistically significant difference in the diagnosis 
of cervical cancer in women who received and did not receive the HPV vaccine 
considering personal risk factors (sexual orientation, cigarette use, diet, and type of 
contraception use)? 
H02: There is no statistically significant difference in the diagnosis of cervical 
cancer in women who received and did not receive the HPV vaccine considering personal 
risk factors (sexual orientation, cigarette use, diet, and type of contraception use). 
H12: There is a statistically significant difference in the diagnosis of cervical 
cancer in women who received and did not receive the HPV vaccine considering personal 
risk factors (sexual orientation, cigarette use, diet, and type of contraception use). 
Research Question 3: Is there a statistically significant difference in the diagnosis 
of cervical cancer in women who received the HPV vaccine based on the number of HPV 
shots received, and the presence of sexual activity? 
H02: There is no statistically significant difference in the diagnosis of cervical 
cancer in women who received the HPV vaccine based on the number of HPV shots 
received, and the presence of sexual activity. 
H12: There is a statistically significant difference in the diagnosis of cervical 
cancer in Remove women who received the HPV vaccine based on the number of HPV 





In 2015, in the United States there were 2,123 females were diagnosed with 
cervical cancer, which is 8.5 per 100,000 (Alabama Statewide Cancer Registry, n.d.). I 
used data from secondary data analysis from the 2017 BRFSS for females between the 
ages of 18 and 60 who had been diagnosed with cervical cancer. 
Sampling and Sampling Procedures 
Based on the research questions and hypotheses, stratified sampling strategy was 
the most appropriate choice for this research study. Specifically, proportional random 
stratified sampling was done by race, which uniformly divided the population into 
different homogenous groups (Frankfort-Nachmias & Nachmias, 2008). Stratified 
sampling strategy ensured that all the groups are uniformly represented. The sample was 
females between 18 to 60 years of age with or without a cervical cancer diagnosis in the 
United States.  
The application used to compute sample size was G*Power version 3.1.9.2. 
Sample size was calculated using effect size, alpha level, and power level. An alpha level 
of 0.05 and a power of 80% was used. Effect size (moderate) provided a higher chance to 
detect a difference between the groups. These parameters were used as these are the most 
feasible levels to avoid Type 1 and Type II errors. Based on these parameters, the sample 




Secondary data from the 2017 BRFSS was used to select the population that met 
my inclusion criteria. This is a publicly available dataset, which I accessed after obtaining 
institutional review board (IRB) approval from Walden University (approval #10-04-19-
0470159). For this secondary data analysis, data were de-identified. Data de-
identification prevents a connection between the information and an individual’s identity 
(Clinical and Intervention Setting, n.d.)The data are stored in a password protected laptop 
and will be destroyed after 5 years. The federal regulations allow for IRBs to exempt 
research using archival data when certain conditions exist, including removing a 
participant’s identity from the data (Institutional Review Board, 2018, para. 1). 
Operationalization of Variables 







 Variable name Variable type 
Survey 
question # Data codes 
 Diagnosis of Cervical DV, Nominal 6.7, 13.3 1 = Yes 
 Cancer   2 = No 
    7 = Don’t know / Not sure 
 HPV Vaccination IV, Nominal 19.1 1 = Yes 
    2 = No 
    3 = Doctor refused when asked 
    7 = Don’t know / Not sure 
    9 = Refused 
 Number of HPV Shots IV, Nominal  19.2 _ _ Number of shots 
    0 3 = All shots 
    77 = Don’t know / Not sure 
 Race IV, Nominal 8.4 10 = White 
    20 = Black or African American 
    30 =American Indian or Alaska Native 
    40 = Asian 
    41 = Asian Indian 
    42 = Chinese 
    43 = Filipino 
    44 = Japanese 
    45 = Korean 
    46 = Vietnamese 
    47 = Other Asian 
    50 = Pacific Islander 
    51 = Native Hawaiian 
    52 = Guamanian or Chamorro 
    53 = Samoan 
 Ethnicity IV, Nominal 8.3 1 = Mexican, Mexican American, Chicano/a 
    2 = Puerto Rican 
    3 = Cuban 
    4 = Another Hispanic, Latino/a, or Spanish origin 
 Level of Education IV, Nominal 8.7 1 = Never attended school or only attended 
kindergarten     
    2 = Grades 1 through 8 (Elementary) 
    3 = Grades 9 through 11 (Some high school) 
    4 = Grade 12 or GED (High school graduate) 
    5 = College 1 year to 3 years (Some college or 
technical school)     
    6 = College 4 years or more (College graduate) 
 Household Income IV, Nominal 8.17 04 = Less than $25,000 ($20,000 to less than $25,000) 
    03 = Less than $20,000 ($15,000 to less than $20,000) 
    02 = Less than $15,000 ($10,000 to less than $15,000) 
    01 = Less than $10,000 
    05 = Less than $35,000 ($25,000 to less than $35,000) 
    06 = Less than $50,000 ($35,000 to less than $50,000) 
    07 = Less than $75,000 ($50,000 to less than $75,000) 




 Variable name Variable type Survey question # Data codes 
 Type of healthcare coverage IV, Nominal 10.2 01 = A plan purchased through an employer or 
union (includes plans purchased through another 
person’s employer) 
    
    
    02 = A plan that you or another family member 
buys on your own     
    03 = Medicare 
    04 = Medicaid or other state program 
    05 TRICARE (formerly CHAMPUS), VA, or 
Military     
    06 = Alaska Native, Indian Health Service, 
Tribal Health Services,     
    07 = Some other source, or 
    08 = None (no coverage) 
 Delay in Medical Care IV, Nominal 10.3 1 = You couldn’t get through on the telephone. 
    2 = You couldn’t get an appointment soon 
enough.     
    3 = Once you got there, you had to wait too long 
to see the doctor.     
    4 = The (clinic/doctor’s) office wasn’t open 
when you got there.     
    5 = You didn’t have transportation. 
 Cigarette Use IV, Nominal 9.2 1 = Every day 
    2 = Some days 
    3 = Not at all 
    7 = Don’t know / Not sure 
    9 = Refused 
 Type of Contraception IV, Nominal 17.1 01 = Female sterilization (e.g., Tubal ligation, 
Essure, Adiana)     
    02 = Male sterilization (vasectomy) 
    03 = Contraceptive implant (e.g., Implanon) 
    04 = Levonorgestrel (LNG) or hormonal IUD 
(e.g., Mirena)     
    05 = Copper-bearing IUD (e.g., ParaGard) 
    06 = IUD, type unknown 
    07 = Shots (e.g., Depo-Provera) 
    08 = Birth control pills, any kind 
    09 = Contraceptive patch (e.g., Ortho Evra) 
   10 = Contraceptive ring (e.g., NuvaRing) 
   11 Male condoms 
   12 = Diaphragm, cervical cap, sponge 
   13 Female condoms 
   14 = Not having sex at certain times (rhythm or 
natural family planning)    
   15 = Withdrawal (or pulling out) 
   16 = Foam, jelly, film, or cream 
   17 = Emergency contraception (morning after 
pill)    
   18 = Other method 
Sexual Activity IV, Nominal 17.1 1 = Yes 
   2,3 = No 
Sexual Orientation IV, Nominal 27.1 1 = Straight 
   2 = Lesbian or gay 




Variable name Variable type Survey question # Data codes 
Diet IV, Nominal 
12.1, 12.3, 12.4, 
12.612.1 
Not including juices, how often did you eat 
fruit? (times per day, week, or month) 
   1_ _ Days 
   2_ _ Weeks 
   3_ _ Months 
   888 = Never 
   777 = Don’t Know 
   999 = Refused 
  
12.3 How often did you eat a green leafy or lettuce 
salad, with or without other vegetables? 
   1_ _ Days 
   2_ _ Weeks 
   3_ _ Months 
   888 = Never 
   777 = Don’t Know 
   999 = Refused 
  
12.6 Not including lettuce salads and potatoes, how 
often did you eat other vegetables? 
   1_ _ Days 
   2_ _ Weeks 
   3_ _ Months 
   888 Never 
   777 = Don’t Know 
   999 = Refused 
  
12.4 How often did you eat any kind of fried 
potatoes, including french fries, home fries, or 
hash browns? 
   1_ _ Days 
   2_ _ Weeks 
   3_ _ Months 
   888 = Never 
   777 = Don’t Know 





The data was collected for all the independent variables-race, ethnicity, level of 
education, household income, type of healthcare coverage, delay in receiving medical 
care, sexual orientation, cigarette use, diet, type of contraception use, number of HPV 
shots received, and the presence of sexual activity. Descriptive data analysis was 
performed to determine frequencies and percentages for the independent variables. 
Binomial logistic regression analysis was used to analyze data from this study. 
Regression analysis is used primarily to analyze variability and provide prediction. It 
predicts the value of a dependent (response) variable based on the value of at least one 
independent (explanatory) variable (Laerd Statistics, 2018). It will be helpful to analyze 
the effect of the independent variables on the dependent variable (Daniel, 2010). 
There are assumptions of binomial logistic regression that need to be met in order 
to generate a valid result. To run binomial logistic regression, it is assumed that the 
dependent variable is measured on a dichotomous scale; there is more than one 
independent variable (either continuous or categorical), observations are independent of 
each other, independent variables should not be in terms with multicollinearity, and linear 
relationship between independent variables and log odds (Laerd Statistics, 2018). 
A correlation matrix is used to determine multicollinear relationships between 
independent variables. If there is multicollinearity between any two predictor variables, 
then the correlation coefficient between these two variables will be near to unity. 
Considering the situation, when two variables strongly correlate with each other or if they 
are measuring the same thing, then the problem of multicollinearity exists. Then, the 
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remedy is to drop one of the predictor variables to lessen the multicollinearity. Otherwise, 
the confidence interval of coefficients becomes wide, statistics tends to be exceedingly 
small, and it becomes difficult to reject the null hypothesis. If it is impossible to drop the 
concerned variable, then alternative methods of estimation like ridge regression or 
principal component regression would be utilized. Multicollinearity was assessed using 
variance inflation factors (VIFs).  
Ridge regression gives an alternative estimator (k) that has a smaller total mean 
square error value. The value of k can be estimated by looking at the ridge trace plot from 
one approach. Ridge trace plot is a plot of parameter estimates vs k where k usually lies 
in the interval of [0,1]. The principal component regression approach combats 
multicollinearity by using less than the full set of principal components in the model. To 
obtain the principal components estimators, assume that the regressors are arranged in 
order of decreasing eigenvalues, λ1 ≥ λ2……. ≥ λp >0. In principal components 
regression, the principal components corresponding to near zero eigenvalues are removed 
from the analysis and least squares applied to the remaining components. However, all 
VIF values were below 10, indicating that multicollinearity was not a concern (see Table 
4, Table 8, and Table 11). I had planned to use ridge regression, but this was not adopted 
as the VIF values were below 10.   
SPSS version 21 was used to analyze data for this study. Records with missing 
data were not included in the analysis. Data from this study were analyzed to answer the 
following research questions: 
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Research Question 1: Is there a statistically significant difference in the diagnosis 
of cervical cancer in women who received and did not receive the HPV vaccine 
considering demographic factors (race, ethnicity, level of education, household income) 
and factors affecting access to healthcare (type of healthcare coverage, delay in receiving 
medical care)? 
H01: There is no statistically significant difference in the diagnosis of cervical 
cancer in women who received and did not receive the HPV vaccine considering 
demographic factors (race, ethnicity, level of education, household income) and factors 
affecting access to healthcare (type of healthcare coverage, delay in receiving medical 
care). 
H11: There is a statistically significant difference in the diagnosis of cervical 
cancer in women who received and did not receive the HPV vaccine considering 
demographic factors (race, ethnicity, level of education, household income) and factors 
affecting access to healthcare (type of healthcare coverage, delay in receiving medical 
care). 
Binomial logistic regression analysis was conducted to answer research question 
one considering the diagnosis of cervical cancer as the dependent dichotomous variable 
and race, ethnicity, level of education, household income, type of healthcare coverage, 
and delay in receiving medical care as independent variables. The null hypothesis was 
rejected if a p value < 0.05 was observed. 
Research Question 2: Is there a statistically significant difference in the diagnosis 
of cervical cancer in women who received and did not receive the HPV vaccine 
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considering personal risk factors (sexual orientation, cigarette use, diet, and type of 
contraception use)? 
H02: There is no statistically significant difference in the diagnosis of cervical 
cancer in women who received and did not receive the HPV vaccine considering personal 
risk factors (sexual orientation, cigarette use, diet, and type of contraception use). 
H12: There is a statistically significant difference in the diagnosis of cervical 
cancer in women who received and did not receive the HPV vaccine considering personal 
risk factors (sexual orientation, cigarette use, diet, and type of contraception use).  
Research Question 3: Is there a statistically significant difference in the diagnosis 
of cervical cancer in women who received the HPV vaccine based on the number of HPV 
shots received and the presence of sexual activity? 
H03: There is no statistically significant difference in the diagnosis of cervical 
cancer in women who received the HPV vaccine based on the number of HPV shots 
received and the presence of sexual activity. 
H13: There is a statistically significant difference in the diagnosis of cervical 
cancer in women who received the HPV vaccine based on the number of HPV shots 
received, and the presence of sexual activity. 
Binomial logistic regression analysis was conducted to answer research question 
two considering the diagnosis of cervical cancer as the dependent dichotomous variable 
and the number of HPV shots received, and the presence of sexual activity as 
independent variables. The null hypothesis was rejected if a p value < 0.05 was observed. 
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Threats to Validity 
There are three types of validity associated with measurement. They are construct 
validity, empirical validity, and content validity (Creswell, 2009). A design is valid when 
it meets the validity with evidence. The validity of the research design is concerned with 
the intervention of factors that stimulate dependent variables. The validity of the research 
design can be easily established if the research design is generalizable and can be easily 
applied to real world situations. The factors outside of the experiment tend to assess 
internal and external validity of the research design. 
The study was associated with internal validity threats. The external validity 
threats were not of concern as the study was carried out using secondary data. However, 
study would not be generalized for external environment with larger population. The 
internal validity threats arose from the previous experiences of the participants that may 
impact the behavior of the participants and influence the result. The threats to statistical 
conclusion validity were addressed by using a p value of < .05 to determine statistical 
significance. 
Reliability of a research design refers to the ability of the study to be trustworthy 
over a period. The reliability of this study could be ensured by using adequate scholarly 
resources as literature review. The reliability of the research design could also be ensured 
by assessing the gaps in the literature and by identifying the reason for this gap with the 
prevailing trends. The research study could address the gaps and should also consider the 




Before conducting my research, approval from the Institutional Review Board 
(IRB) at Walden University was obtained (IRB# 10-04-19-0470159). Approval through 
written agreements that would provide access to data was obtained. Consent was not 
required as secondary data was used. Data was de-identified and anonymous. The data 
collected is stored in a password protected laptop. The data is accessible only by myself 
and will destroy the data by deleting from my laptop after 5 years from the end of my 
research study. 
Summary 
This research study used quantitative research methodology and consisted of 
secondary data analysis from the 2017 BRFSS. I analyzed data about cervical cancer 
diagnosis, HPV vaccination, demographics, and personal risk factors for cervical cancer 




Chapter 4: Results 
The purpose of this study was to determine whether there was a statistically 
significant difference in cervical cancer diagnosis between women who received the HPV 
vaccine and those who did not, with consideration for demographic factors (race, 
ethnicity, level of education, household income), personal risk factors (sexual orientation, 
cigarette use, diet, and type of contraception use), and factors affecting access to 
healthcare (type of healthcare coverage, delay in receiving medical care). I also examined 
whether there was a difference in cervical cancer diagnosis in women who received the 
HPV vaccine based on the number of HPV shots received and the presence of sexual 
activity. Chapter 4 includes information about data collection and results of statistical 
analysis.  
Data Collection 
For this study, secondary data from the 2017 BRFSS were analyzed. Because 
there were no data available for cervical cancer diagnosis or HPV vaccination for the 
cases in Alabama, I analyzed data from all females in the 2017 dataset. The independent 
variables were race, ethnicity, level of education, household income, type of healthcare 
coverage, delay in receiving medical care, sexual orientation, cigarette use, diet, type of 
contraception use, number of HPV shots received, and the presence of sexual activity. 
The dependent variable of the study was the diagnosis of cervical cancer. 
There was a total of 251,007 female cases in the dataset. Table 2 displays 
descriptive statistics for the demographic variables in this sample. Most women in the 
sample identified as White (n = 203,237, 81.0%) and not Hispanic (n = 228,267, 90.9%). 
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The largest proportion of women had earned a college degree or higher (n = 92,050, 
36.7%). The largest proportion of women had an income level of $75,000 per year or 






Frequencies and Percentages for Demographic Variables 
Variable Frequency Percent 
Race   
White 203,237 81.0 
Black or African American 23,731 9.5 
American Indian or Alaskan Native 5,763 2.3 
Asian 5,230 2.1 
Hawaiian or Pacific Islander 1,662 0.7 
Other 5,013 2.0 
No preferred race 792 0.3 
Do not know 2,206 0.9 
Missing 3,373 1.3    
Ethnicity 
  
Hispanic 20,534 8.2 
Not Hispanic 228,267 90.9 
Missing 2,206 0.9    
Education level 
  
Never attended 322 0.1 
Elementary 5,663 2.3 
Some high school 11,973 4.8 
High school 67,114 26.7 
Some college 72,965 29.1 
College graduate 92,050 36.7 
Missing 920 0.4    
Income level 
  
Less than $10,000 11,647 4.6 
Less than $15,000 12,256 4.9 
Less than $20,000 17,182 6.8 
Less than $25,000 20,447 8.1 
Less than $35,000 22,909 9.1 
Less than $50,000 28,603 11.4 
Less than $75,000 31,201 12.4 
$75,000 or more 59,486 23.7 
Do not know 21,909 8.7 





Research Question 1 
Research Question 1: Is there a statistically significant difference in the diagnosis 
of cervical cancer in women who received and did not receive the HPV vaccine 
considering demographic factors (race, ethnicity, level of education, household income) 
and factors affecting access to healthcare (type of healthcare coverage, delay in receiving 
medical care)? Table 3 displays descriptive statistics for the variables included in 
Research Question 1. Less than 1% of women in the sample had a cervical cancer 
diagnosis and had received the HPV vaccine. Additionally, approximately 90% of the 
sample had no data available for type of healthcare coverage or delay in medical care. 
After list wise exclusion of cases missing data for these variables, no cases with cervical 
cancer diagnoses remained. Therefore, to conduct the analysis for Research Question 1, 
the variables for type of healthcare coverage and delay in receiving medical care were 






Frequencies and Percentages for Cervical Cancer Diagnosis, HPV Vaccination, 
Healthcare Coverage, and Delay in Medical Care 
Variable Frequency Percent 
Cervical cancer diagnosis   
No 250,754 99.9 
Yes 253 0.1    
Received HPV vaccine 
  
No 249,905 99.6 
Yes 1,102 0.4    
Primary health insurance coverage 
  
Employer plan 8,704 3.5 
Own plan 2,555 1 
Medicare 8,350 3.3 
Medicaid or state program 2,134 0.9 
TRICARE VA or Military 414 0.2 
Indian Health Service 29 0 
Other 825 0.3 
None 24 0 
Do not know 231 0.1 
Missing 227,741 90.7    
Delayed getting medical care 
  
Could not get through on phone 328 0.1 
Could not get appointment 1,753 0.7 
Doctor wait was too long 784 0.3 
Doctor office was not open 189 0.1 
No transportation 1,201 0.5 
Other 1,273 0.5 
Do not know 138 0.1 
No delay 19,847 7.9 





Additionally, a binary logistic regression was conducted to address this question, 
with the dependent variable being cervical cancer diagnosis. Before interpreting the 
results of the regression, multicollinearity was assessed using VIFs. All VIF values were 
below 10, indicating that multicollinearity was not a concern (see Table 4). 
Table 4 
 
Variance Inflation Factors for Research Question 1  
Variable VIF 






The result for the overall binary logistic regression model was significant, χ
2
(22) 
= 142.21, p < .001, suggesting that collectively the independent variables significantly 
predicted cervical cancer diagnosis. The Cox and Snell R2 and Nagelkerke R2 were .001 
and .039, respectively, indicating the predictors accounted for 0.10 – 3.90% of the 
variance in cervical cancer diagnosis. Receiving the HPV vaccine was a significant 
predictor of cervical cancer diagnosis, B = 1.17, OR = 3.23, p = .044, indicating that, 
after controlling for the demographic variables, women who received the HPV vaccine, 
were 3.23 times more likely to have a diagnosis of cervical cancer. Because there was a 
significant difference in cervical cancer diagnosis between women who received and did 
not receive the HPV vaccine, the null hypothesis was rejected. Table 5 presents the 




Binary Logistic Regression Predicting Cervical Cancer Diagnosis (Research Question 1) 
Variable B SE χ
2
 p OR 
(Intercept) -6.62 0.80 68.12 < .001   
HPV vaccine 1.17 0.58 4.04 .044 3.23 
Race: White -0.84 0.75 1.23 .266 0.43 
Race: Black or African American -1.99 0.82 5.96 .015 0.14 
Race: American Indian or Alaskan Native -0.00 0.79 0.00 1.000 1.00 
Race: Asian -2.41 1.25 3.69 .055 0.09 
Race: Hawaiian or Pacific Islander -13.64 264.29 0.00 .959 0.00 
Race: Other -0.97 1.00 0.94 .332 0.38 
Race: No preferred race -0.64 1.25 0.26 .611 0.53 
Ethnicity: Hispanic -1.93 0.50 14.95 < .001 0.15 
Education: Never attended -11.70 609.50 0.00 .985 0.00 
Education: Elementary 0.84 0.40 4.29 .038 2.31 
Education: Some high school -0.07 0.36 0.04 .837 0.93 
Education: High school 0.42 0.19 4.75 .029 1.53 
Education: Some college 0.51 0.19 7.50 .006 1.66 
Income: Less than $10,000 1.24 0.33 14.31 < .001 3.47 
Income: Less than $15,000 1.14 0.32 12.37 < .001 3.13 
Income: Less than $20,000 0.85 0.32 6.90 .009 2.33 
Income: Less than $25,000 0.86 0.31 7.71 .005 2.37 
Income: Less than $35,000 0.43 0.33 1.72 .190 1.54 
Income: Less than $50,000 0.52 0.31 2.80 .094 1.69 
Income: Less than $75,000 0.11 0.33 0.11 .744 1.11 




The Black category of race was a significant predictor of cervical cancer 
diagnosis, B = -1.99, OR = 0.14, p = .015, indicating that Black or African American 
individuals were 0.14 times as likely to have a diagnosis of cervical cancer. Ethnicity was 
a significant predictor of cervical cancer diagnosis, B = -1.93, OR = 0.15, p < .001, 
indicating that Hispanic individuals were 0.15 times as likely to have a diagnosis of 
cervical cancer. The elementary, high school, and some college categories of education 
were significant predictors of cervical cancer diagnosis (p-values < .05), indicating that 
individuals with elementary, high school, or some college levels of education were more 
likely to have a diagnosis of cervical cancer. The income categories less than $25,000 
were significant predictors of cervical cancer diagnosis (p-values < .05), indicating that 
individuals with income levels less than $25,000 were more likely to have a diagnosis of 
cervical cancer. 
Research Question 2 
Is there a statistically significant difference in the diagnosis of cervical cancer in 
women who received and did not receive the HPV vaccine considering personal risk 
factors (sexual orientation, cigarette use, diet, and type of contraception use)? The 
independent variables for Research Question 2 included HPV vaccination, sexual 
orientation, cigarette use, diet (calculated daily servings of fruit, greens, other vegetables, 
and fried potatoes), and type of contraception use. The dependent variable was diagnosis 
of cervical cancer. Tables 6 and 7 display descriptive statistics for the variables included 





Frequencies and Percentages for Sexual Orientation, Cigarette Use, and Type of 
Contraception 
Variable Frequency Percent 
Sexual orientation     
    Do not know 1,251 0.50 
    Straight 106,595 42.47 
    Lesbian or gay 1,330 0.53 
    Bisexual 2,303 0.92 
    Other 559 0.22 
    Missing 138,969 55.36 
Cigarette use     
    Every day 23,046 9.18 
    Never smoked 147,974 58.95 
    Not at all 60,448 24.08 
    Some days 9,567 3.81 
    Missing 9,972 3.97 
Type of contraception     
    Do not know 94 0.04 
    None or NA 23,945 9.54 
    Female sterilization 1,953 0.78 
    Male sterilization 1,870 0.74 
    Implant 816 0.33 
    LNG or IUD 795 0.32 
    Copper bearing IUD 466 0.19 
    Other IUD 1,839 0.73 
    Shots 446 0.18 
    Pills 5,017 2.00 
    Patch 101 0.04 
    Ring 191 0.08 
    Male condoms 5,148 2.05 
    Diaphragm 47 0.02 
    Female condoms 121 0.05 
    Rhythm or natural 117 0.05 
    Withdrawal 427 0.17 
    Foam jelly film or cream 29 0.01 
    Emergency contraception 37 0.01 
                     
   Other 
638 0.25 





Means and Standard Deviations for Diet Variables (Calculated Daily Servings) 
Variable M SD 
Fruit 1.25 1.78 
Greens 0.65 1.35 
Other vegetables 1.10 2.12 
Fried potatoes 0.17 0.39 
 
A binary logistic regression was conducted to address this question, with the 
dependent variable being cervical cancer diagnosis. Before interpreting the results of the 
regression, multicollinearity was assessed using VIFs. All VIF values were below 10, 
indicating that multicollinearity was not a problem (see Table 8). 
Table 8 
 
Variance Inflation Factors for Research Question 2 
Variable VIF 
HPV vaccine 1.03 
Sexual orientation 1.03 
Cigarette use 1.11 
Fruit 3.90 
Greens 1.02 
Other vegetables 3.85 
Fried potatoes 1.03 
Contraception 1.06 
  
The result for the overall binary logistic regression model was significant, χ2(31) 
= 52.42, p = .009, suggesting that collectively the independent variables significantly 
predicted cervical cancer diagnosis. The Cox and Snell R2 and Nagelkerke R2 were .002 
and .138, respectively, indicating the model accounted for 0.20 – 13.80% of the variance 
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in cervical cancer diagnosis. Receiving the HPV vaccine was a significant predictor of 
cervical cancer diagnosis, B = 2.00, OR = 7.40, p = .002, indicating that, after controlling 
for the personal risk factors, women who received the HPV vaccine, were 7.40 times 
more likely to have a diagnosis of cervical cancer. Because there was a significant 
difference in cervical cancer diagnosis between women who received and did not receive 
the HPV vaccine, the null hypothesis was rejected. Table 9 presents the regression 






Binary Logistic Regression Predicting Cervical Cancer Diagnosis (Research Question 2) 
Variable B SE χ
2
 p OR 
(Intercept) -35.28 6770.79 0.00 .996   
HPV vaccine 2.00 0.63 9.98 .002 7.40 
Orientation: Straight 14.68 2809.52 0.00 .996 2.38 × 10
6
 
Orientation: Lesbian or gay -1.13 3544.68 0.00 1.000 0.32 
Orientation: Bisexual 15.82 2809.52 0.00 .996 7.44 × 10
6
 
Orientation: Other -0.61 4765.54 0.00 1.000 0.54 
Cigarettes: Never smoked -2.54 0.55 21.32 < .001 0.08 
Cigarettes: Not at all -1.33 0.59 5.12 .024 0.26 
Cigarettes: Some days -0.63 0.66 0.93 .334 0.53 
Fruit 0.11 0.10 1.22 .269 1.12 
Greens -0.27 0.40 0.46 .500 0.77 
Other vegetables -0.04 0.11 0.13 .721 0.96 
Fried potatoes -0.98 0.95 1.05 .305 0.38 
Contraception: None or NA 15.23 6160.37 0.00 .998 4.11 × 10
6
 
Contraception: Female sterilization 16.29 6160.37 0.00 .998 1.19 × 10
7
 
Contraception: Male sterilization 15.47 6160.37 0.00 .998 5.22 × 10
6
 
Contraception: Implant -0.41 6453.94 0.00 1.000 0.66 
Contraception: LNG or IUD -0.39 6542.14 0.00 1.000 0.67 
Contraception: Copper bearing IUD -0.25 6724.47 0.00 1.000 0.78 
Contraception: Other IUD -0.29 6319.41 0.00 1.000 0.75 
Contraception: Shots -0.68 6734.43 0.00 1.000 0.51 
Contraception: Pills 14.84 6160.37 0.00 .998 2.79 × 10
6
 
Contraception: Patch -0.31 8251.77 0.00 1.000 0.74 
Contraception: Ring -0.27 7370.15 0.00 1.000 0.76 
Contraception: Male condoms 14.77 6160.37 0.00 .998 2.60 × 10
6
 
Contraception: Diaphragm -0.07 13024.04 0.00 1.000 0.93 
Contraception: Female condoms -0.40 8493.15 0.00 1.000 0.67 
Contraception: Rhythm or natural -0.15 8452.18 0.00 1.000 0.86 
Contraception: Withdrawal -0.59 6742.15 0.00 1.000 0.56 
Contraception: Foam jelly film or 
cream 
-1.69 12147.21 0.00 1.000 0.18 
Contraception: Emergency 
contraception 
0.04 11213.87 0.00 1.000 1.05 




The “never smoked” and “not at all” categories of cigarette use were significant 
predictors of cervical cancer diagnosis (p-values < .05), indicating that individuals who 
smoked never or not at all were less likely to have a diagnosis of cervical cancer. 
Research Question 3 
Is there a statistically difference in the diagnosis of cervical cancer in women who 
received the HPV vaccine based on the number of HPV shots received, and the presence 
of sexual activity? The independent variables for Research Question 3 included the 
number of HPV shots received, and the presence of sexual activity. The dependent 
variable was diagnosis of cervical cancer. Table 10 displays descriptive statistics for the 
variables included in Research Question 3. 
Table 10 
 
Frequencies and Percentages for HPV Shots and Sexual Activity 
Variable Frequency Percent 
Number of HPV shots   
Do not know 159 0.06 
1 234 0.09 
2 175 0.07 
All shots 529 0.21 
Missing 249,910 99.56 
Sexually active   
Yes 40,781 16.25 
No 4,167 1.66 
Missing 206,059 82.09 
 
A binary logistic regression was conducted to address this question, with the 
dependent variable being cervical cancer diagnosis. Only women who had received the 
HPV vaccine were included in this analysis. Before interpreting the results of the 
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regression, multicollinearity was assessed using VIFs. All VIF values were below 10 
(1.00 for race, HPV shots, and sexual activity), indicating that multicollinearity was not a 
problem. 
  
The result for the overall binary logistic regression model was not significant, 
χ2(11) = 5.85, p = .883, suggesting that collectively the independent variables did not 
significantly predict cervical cancer diagnosis. The Cox and Snell R2 and Nagelkerke R2 
were .009 and .155, respectively, indicating the predictors accounted for 0.90 – 15.50% 
of the variance in cervical cancer diagnosis. Because no predictors were significant, the 
null hypothesis was not rejected. Table 11 presents the regression coefficients for the 
binary logistic regression. 
Table 11 
 
Binary Logistic Regression Predicting Cervical Cancer Diagnosis (Research Question 3) 
Variable B SE  χ
2
 p OR 
(Intercept) -36.43 10387.27  0.00 .997 0.00 
Race: White 14.93 9438.04  0.00 .999 3047555.36 
Race: Black or African American 15.33 9438.04  0.00 .999 4527623.96 




0.00 1.000 0.77 
Race: Asian -0.97 12558.00  0.00 1.000 0.38 




0.00 1.000 4071007.96 
Race: Other -0.63 19209.57  0.00 1.000 0.53 
Race: No preferred race -1.29 41286.21  0.00 1.000 0.28 
Shots: 1 -0.01 5295.46  0.00 1.000 0.99 
Shots: 2 0.04 5730.43  0.00 1.000 1.04 
Shots: All 16.52 4338.06  0.00 .997 14876606.39 





Three binary logistics regression analyses were conducted to answer the research 
questions. The results for Research Question 1 showed that there was a significant 
difference in the diagnosis of cervical cancer in women who received and did not receive 
the HPV vaccine after controlling for demographic factors; the null hypothesis was 
rejected. The results for Research Question 2 showed that there was a significant 
difference in the diagnosis of cervical cancer in women who received and did not receive 
the HPV vaccine after controlling for personal risk factors; the null hypothesis was 
rejected. The results for Research Question 3 showed that there were no differences in the 
diagnosis of cervical cancer in women who received the HPV vaccine based on the 
number of HPV shots received, or the presence of sexual activity; the null hypothesis was 
not rejected. Chapter 5 will contain a discussion of results, limitations, and 
recommendations for future research. 
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Chapter 5: Discussion, Conclusions, and Recommendations 
The purpose of this study was to determine if there was a statistically significant 
difference in the diagnosis of cervical cancer in women who received the HPV vaccine as 
compared to women who did not receive the vaccine, with the consideration of 
demographic factors (race, ethnicity, level of education, household income), personal risk 
factors (sexual orientation, cigarette use, diet, and type of contraception use), and factors 
affecting access to healthcare (type of healthcare coverage, delay in receiving medical 
care). In addition, I also examined if there was a difference in the diagnosis of cervical 
cancer in women who received the HPV vaccine based on the number of HPV vaccines 
received and the presence of sexual activity. 
Cervical cancer has been the third most diagnosed cancer and the fourth leading 
cause of cancer death in females worldwide (Miller, 2016). In 2017, 12,820 women in the 
United States were diagnosed with cervical cancer and 4,210 deaths from the disease 
occurred (ASCO, 2018). However, a decreased amount of research has been identified 
about personal risk factors for cervical cancer, factors affecting access to health care, and 
HPV vaccination in women based on demographic factors. It is also important to 
determine the accurate time when HPV vaccine should be administered among teenage 
females to enhance the effectiveness of HPV vaccine. In this study, I intended to address 
the gap in the literature regarding the underlying causes of higher death rates in certain 
racial groups of females due to cervical cancer. I examined whether there was a 
difference in cancer diagnosis between those who did and did not receive the HPV 
vaccine based on demographic factors (race, ethnicity, level of education, household 
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income), personal risk factors (sexual orientation, cigarette use, diet, and type of 
contraception use), and factors affecting access to healthcare (type of healthcare 
coverage, delay in receiving medical care). I also examined number of HPV vaccines and 
sexual activity. For this quantitative study, I conducted secondary data analysis from the 
2017 BRFSS. Data were selected from females between the ages of 18 to 60, who have 
been diagnosed with cervical cancer, as well as females who tested negative for cervical 
cancer. 
The results of this study showed that there was a significant difference in the 
diagnosis of cervical cancer in women who received and did not receive the HPV vaccine 
after controlling for demographic factors and a significant difference in the diagnosis of 
cervical cancer in women who received and did not receive the HPV vaccine after 
controlling for personal risk factors. The findings also showed that there was no 
significant difference in the diagnosis of cervical cancer in women who received the HPV 
vaccine based on the number of HPV shots received or the presence of sexual activity. In 
this chapter, I will provide an interpretation of the findings, limitations of the study, 
recommendations, and implications.   
Interpretation of the Findings 
The significant findings from this study suggest that patients should inquire about 
their health care coverage to receive the HPV vaccine. Approximately 90% of the sample 
had no data available for the type of healthcare coverage or delay in medical care. 
Considering list wise exclusion of cases missing data for these variables, no cases with 
cervical cancer diagnoses remained.  
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Additionally, the significant findings from this study suggest that Black women 
should see their oncologist for reliable cervical cancer diagnosis. The Black category of 
race was a significant predictor of cervical cancer diagnosis, B = -1.99, OR = 0.14, p = 
.015, indicating that Black or African American individuals were 0.14 times as likely to 
have a diagnosis of cervical cancer. Ethnicity was also a significant predictor of cervical 
cancer diagnosis, B = -1.93, OR = 0.15, p < .001, indicating that Hispanic individuals 
were 0.15 times as likely to have a diagnosis of cervical cancer. Regarding other 
demographic factors, the elementary, high school, and some college categories of 
education were significant predictors of cervical cancer diagnosis (p < .05), indicating 
that individuals with these levels of education were more likely to have a diagnosis of 
cervical cancer. The income categories less than $25,000 were significant predictors of 
cervical cancer diagnosis (p < .05), indicating that individuals with income levels less 
than $25,000 were more likely to have a diagnosis of cervical cancer. If income is less 
than $25,000 annually, this would not be sufficient to cover medical procedures. 
Additionally, the results revealed that the HPV vaccine should be provided 
because there was a significant difference in cervical cancer diagnosis between women 
who received and did not receive the HPV vaccine. Receiving the HPV vaccine was a 
significant predictor of cervical cancer diagnosis, B = 2.00, OR = 7.40, p = .002, 
indicating that, after controlling for the personal risk factors, women who received the 
HPV vaccine were 7.40 times more likely to have a diagnosis of cervical cancer. 
The study addressed the gap in the literature by identifying possible demographic 
and personal risk factors for cervical cancer leading to higher death rates in certain racial 
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groups of females (Tabatbhai et al., 2014). Additionally, the social cognitive theory 
helped explain the pattern of change in human behavior regarding administration of HPV 
vaccine during adolescence. The dependent constructs of the theory are learning and 
change in behavior, which can be measured in terms of incidence of cervical cancer; 
independent constructs are personal factors (initiation of sexual activity, ethnicity, and 
lifestyle), behavior (socioeconomic status), and environment (geographic location). The 
dependent constructs of the theory depend on and responds to independent constructs of 
the theory. Thus, this theory helped to explain the incidence of cervical cancer as an 
interaction of personal factors (initiation of sexual activity), behavior (lifestyle), and 
environment (geographic location, socioeconomic status; Bandura, 1989). 
Limitations of the Study 
The major limitation of the study was that the data collected through a 
questionnaire may be biased and the patients may not have provided correct information. 
As I used secondary data for my analysis, I was not able to address these limitations. The 
progress in the HPV vaccine over the period when it was administered to the selected 
sample and the time of the research study is another major limitation. The gap between 
the time of the collected data and the timing of the research study has witnessed 
technological changes that might affect the validity of the research. To address this 
limitation, I used the most recent available data relevant to my research study. 
Recommendations 
As no research has been found about HPV vaccination in women living in 
Alabama, a recommendation for future research would be to conduct a quantitative study 
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on women from Alabama to provide confirmation of consistency of the findings in 
reference to the difference in the diagnosis of cervical cancer in women who received the 
HPV vaccine compared to women who did not receive the vaccine. Demographic factors 
(race ethnicity, county of residence, level of education, household income), personal risk 
factors (sexual orientation, cigarette use, diet, and type of contraception use), and factors 
affecting access to healthcare (type of healthcare coverage, delay in receiving medical 
care) should be considered in this recommendation.  
Additionally, implementing a qualitative study with a phenomenological approach 
could help determine how women should schedule cervical examinations with their 
physicians. These objectives can proceed to address and close the gap in literature about 
HPV vaccination and cervical cancer because of lack of research that has been stipulated 
in reference to personal risk factors, factors affecting access to health care, and HPV 
vaccination in women based on demographic factors. 
Implications of Findings 
The findings of the study were generally aligned with the literature of the topic of 
the study. These results indicate a reflection on the demographic and personal risk factors 
for cervical cancer in a certain group of females. The results also provide insight on a 
perspective of education, income, health care coverage, receiving medical care. These 
results may inform the structure of patient care, which could provide individuals with 
guidance throughout the process of treatment if cervical cancer is detected. The potential 
positive social change that could result from this study is increased rate and timely 
administration of HPV vaccination for women, which may lead to decreased death rates 
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from cervical cancer. The results of this study can also raise awareness in education for 
families, organizations, and the society. These objectives can encourage the public to take 
advantage of their health by regularly visiting their healthcare providers annually to 
ensure that they are in proper health. Women should consult with their physician for 
reliable testing to confirm a diagnosis of HPV and vaccines. If there is a situation when 
health care cost is unaffordable, patients can seek nonprofit organizations for their health 
care necessaries. Enough health care coverage should be provided in the process of 
receiving treatment because this plays a major role in the quality of health care treatment 
received.  
Summary and Conclusion  
This research study used a quantitative research methodology and consisted of 
secondary data analysis from the 2017 BRFSS for females ages 18 to 60 diagnosed with 
cervical cancer as well as those who tested negative for cervical cancer. Females may or 
may not have received the HPV vaccine. Results of this study revealed that there was a 
statistically significant difference in the diagnosis of cervical cancer in women who 
received and did not receive the HPV vaccine after controlling for demographic factors 
and a statistically significant difference in the diagnosis of cervical cancer in women who 
received and did not receive the HPV vaccine after controlling for personal risk factors. 
Based on the findings of this study, health care organizations may wish to raise 
awareness of cervical cancer among certain racial groups. Furthermore, because of the 
increased rates of cervical cancer in certain racial groups, there should be a more 




Allen, A. N. (2004). Social cognitive theory in diabetes exercise research: An integrative 
literature review. The Diabetes Educator, 30(5). 
https://doi.org/10.1177/014572170403000516 
Al-Shaikh, G. K., Almussaed, E. M., Fayed, A. A., Khan, F. H., Syed, S. B., Al-Tamimi, 
T. N., & Elmorshedy, H. N. (2014). Knowledge of Saudi female university 
students regarding cervical cancer and acceptance of the human papilloma virus 
vaccine. Saudi Medical Journal, 35(10), 1223–1230. 
American Cancer Society. (2018). What is cervical cancer? 
https://www.cancer.org/cancer/cervical-cancer/about/what-is-cervical-cancer.html 
Anhang, P. R., Koshiol, J., Kobrin, S., & Tiro, J. A. (2011). Knowledge and intention to 
participate in cervical cancer screening after the human papillomavirus vaccine. 
Vaccine, 29(25), 4238–4243. https://doi.org/10.1016/j.vaccine.2011.03.076 
Alabama Statewide Cancer Registry. (n.d.). Data years: 2004-2013 (Incidence and 
Mortality). https://www.alabamapublichealth.gov/ascr/index.html  
Arbyn, M., Snijders, P. J. F., Meijer, C. J. L. M., Berkhof, J., Cuschieri, K., Kocjan, B. J., 
& Poljak, M. (2015). Which high-risk HPV assays fulfil criteria for use in primary 
cervical cancer screening? Clinical Microbiology and Infection, 21(9), 817–826. 
https://doi.org/10.1016/j.cmi.2015.04.015 
Assoumou, S. Z., Mabika, B. M., Mbiguino, A. N., Mouallif, M., Khattabi, A., & Ennaji, 
(2015). Awareness and knowledge regarding of cervical cancer, Pap smear 
screening and human papillomavirus infection in Gabonese women. BMC 
73 
 
Women’s Health, 15, 37. https://doi.org/10.1186/s12905-015-0193-2 
Bandura, A. (1989). Social cognitive theory. In R. Vasta (Ed.), Annals of child 
development (pp. 1–60). JAI Press. 
Bandura, A. (2004) Health promotion by social cognitive means. Health Education & 
Behavior, 31, 143–164. http://dx.doi.org/10.1177/1090198104263660 
Barchitta, M., Maugeri, A., Quattrocchi, A., Agrifoglio, O., Scalisi, A., & Agodi, A. 
(2018). The association of dietary patterns with high-risk human papillomavirus 
infection and cervical cancer: A cross-sectional study in Italy. Nutrients, 10(4), 
469. http://doi.org/10.3390/nu10040469 
Blake, K., Ottenbacher, A., Finney, R. L. J., Grady, M., Kobrin, S., Jacobson, R., & 
Hesse, B. W. (2015). Predictors of human papillomavirus awareness and 
knowledge in 2013: Gaps and opportunities for targeted communication 
strategies. American Journal of Preventive Medicine, 48(4), 402–410. 
Booth, F. W., Roberts, C. K., & Laye, M. J. (2012). Lack of exercise is a major cause of 
chronic diseases. Comprehensive Physiology, 2(2), 1143–1211. 
http://doi.org/10.1002/cphy.c110025 
Cervical cancer. (n.d.). 
http://www.cancer.org/Cancer/CervicalCancer/OverviewGuide/index 
Chen, M. (2018, December 17). The state where Black women are twice as likely to die 




Clinical and Intervention Setting. (n.d.). Retrieved from academicguides.waldenu.edu: 
https://academicguides.waldenu.edu/research-center/research-ethics/clinical-
intervention 
Daley, E., Perrin, K., Vamos, C., Hernandez, N., Anstey, E., Baker, E., Kolar, S., & 
Ebbert, J. (2013). Confusion about Pap smears: Lack of knowledge among high-
risk women. Journal of Women’s Health, 1, 67–74. 
https://doi.org/10.1089/jwh.2012.3667 
Deanna, K., Zahava, B. K., Robin, Y., Katherine, R., & Mona, S. (2012). Human 
papillomavirus vaccine practices in the USA: Do primary care providers use 
sexual history and cervical cancer screening results to make HPV vaccine 
recommendations? Sexually Transmitted Infections, 88(6), 433–435. 
https://doi.org/10.1136/sextrans-2011-050437 
Dorell, C., Yankey, D., Kennedy, A., & Stokley, S. (2012). Factors that influence 
parental vaccination decisions for adolescents, 13 to 17 years old: National 
Immunization Survey-Teen, 2010. Clinical Pediatrics, 52(2), 162–170. 
https://doi.org/10.1177/0009922812468208 
D’Orazio, L. M., Taylor-Ford, M., & Meyerowitz, B. E. (2014). Cervical cancer 
prevention among Latinas in a post-HPV vaccine world: Considering the 
sociocultural context. Women & Therapy, 37(3/4), 264–281. 
https://doi.org/10.1080/02703149.2014.897552 
Finer, L. B., & Philbin, J. M. (2013). Sexual initiation, contraceptive use, and pregnancy 




Garcés-Palacio, I. C., & Scarinci, I. C. (2012). Factors associated with perceived 
susceptibility to cervical cancer among Latina immigrants in Alabama. Maternal 
and Child Health Journal, 16(1), 242–248. https://doi.org/10.1007/s10995-010-
0737-x 
Gravitt, P. E. (2011). The known unknowns of HPV natural history. Journal of Clinical 
Investigation, 121(12), 4593–4599. https://doi.org/10.1172/JCI57149 
Guglielmo, R., Joakim, D., Miriam, E., Sara, T., Peter, J. F. S., Marc, A., Henry, K., 
Nereo, S., Clare, G., Paolo, R., Johannes, B., Julian, P., & Chris, J. L. M. (2014). 
Efficacy of HPV-based screening for prevention of invasive cervical cancer: 
Follow-up of four European randomised controlled trials. The Lancet, 383(9916), 
524–532. https://doi.org/10.1016/S0140-6736(13)62218-7 
Guo, L., Zhu, H., Lin, C., Che, J., Tian, X., Han, S., Zhao, H., Zhu, Y., & Mao, D. 
(2015). Associations between antioxidant vitamins and the risk of invasive 
cervical cancer in Chinese women: A case-control study. Scientific Reports, 5, 
13607. https://doi.org/10.1038/srep13607 
Hastings, T. J., Hohmann, L. A., McFarland, S. J., Teeter, B. S., & Westrick, S. C. 
(2017). Pharmacists’ attitudes and perceived barriers to human papillomavirus 
(HPV) vaccination services. Pharmacy (Basel, Switzerland), 5(3), 45. 
https://doi.org/10.3390/pharmacy5030045 
Holman, D. M., Benard V., Roland, K. B., Watson, M., Liddon, N., & Stokley, S. (2014). 
Barriers to human papillomavirus vaccination among US adolescents: A 
76 
 
systematic review of the literature. JAMA Pediatrics, 168, 76–82. 
https://doi.org/10.1001/jamapediatrics.2013.2752 
iMedPub. (2018). Dietary habits. http://www.imedpub.com/scholarly/dietary-habits-
journals-articles-ppts-list.php 
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011). Global 
cancer statistics. A Cancer Journal for Clinicians, 61, 69–90. 
https://doi.org/10.3322/caac.20107 
Hartas, D. (2010). Educational research and inquiry: Qualitative and quantitative 
approaches. Bloomsbury Publishing. 
Hawkins, N. A., Berkowitz, Z., & Peipins, L. A. (2010). What does the public know 
about preventing cancer? Results from the Health Information National Trends 
Survey (HINTS). Health Education & Behavior, 37(4), 490–503. 
Hirth, J. M., Laz, T. H., Rahman, M., & Berenson, A. B. (2015). Racial/ethnic 
differences affecting adherence to cancer screening guidelines among women. 
Journal of Women’s Health, 25(4), 371–380. 
http://doi.org/10.1089/jwh.2015.5270 
Institutional Review Board for Social and Behavioral Sciences. (2018). Archival data. 
http://www.virginia.edu/vpr/irb/sbs/submissions_review_ex_exemption_arch.htm
l 
Jassim, G., Obeid, A., & Huda, A. (2018). Knowledge, attitudes, and practices regarding 
cervical cancer and screening among women visiting primary health care centres 




Kessels, S. J., Marshall, H. S., Watson, M., Braunack-Mayer, A. J., Reuzel, R., & 
Tooher, R. L. (2012). Factors associated with HPV vaccine uptake in teenage 
girls: A systematic review. Vaccine, 30(24), 3546–3556. 
https://doi.org/10.1016/j.vaccine.2012.03.063 
Kontos, E.Z., Emmons, K.M., Puleo, E., & Viswanath, K. (2012). Contribution of 
communication inequalities to disparities in human papillomavirus vaccine 
awareness and knowledge. American Journal of Public Health, 102(10),1911-20. 
Laerd Statistics. (2018). Binomial logistic regression using SPSS statistics. Lund 
Research Ltd. https://statistics.laerd.com/spss-tutorials/binomial-logistic-
regression-using-spss-statistics.php. 
Lai, J.Y., Tinker, A.V., & Cheung, W.Y. (2013). Factors influencing the willingness of 
US women to vaccinate their daughters against the human papillomavirus to 
prevent cervical cancer. Medical Oncology, 30(2), 582. doi: 10.1007/s12032-013-
0582-z. 
LaMorte, W. (2016). The social cognitive theory. Boston University School of Public 
Health. http://sphweb.bumc.bu.edu/otlt/MPH-
Modules/SB/BehavioralChangeTheories/BehavioralChangeTheories5.html 
Madadi, M., Zhang, S., Yeary, K.H., & Henderson, L.M. (2014). Analyzing factors 
associated with women’s attitudes and behaviors toward screening mammography 




Markowitz, L.E., Dunne, E.F., & Saraiya, M. (2014). Human papillomavirus vaccination: 
Recommendations of the Advisory Committee on Immunization Practices (ACIP) 
MMWR Recommendations Report, 63 (RR-05), 1-30. 
Mayne, S.T., Playdon, M.C., & Rock, C.L. (2016). Diet, nutrition, and cancer: Past, 
present and future. Nature Reviews Clinical Oncology, 13 (504–515). 
McHugh M. L. (2013). The Chi-square test of independence. Biochemia Medica, 23(2), 
143-9. doi: 10.11613/BM.2013.018 
Nan, X., Zhao, X., & Briones, R. (2014). Parental cancer beliefs and trust in health 
information from medical authorities as predictors of HPV vaccine acceptability. 
Journal of Health Communication, 19(1), 100-14. 
Oncology - cervical cancer; Cervical cancer death rates higher among older and Black 
women. (2017, Feb 06). Cancer Vaccine Week. 
https://ezp.waldenulibrary.org/login?url=https://search-proquest-
com.ezp.waldenulibrary.org/docview/1863978742?accountid=14872 
Patton, M. Q. (2015). Qualitative research & evaluation methods: Integrating theory and 
practice (4th ed.). Thousand Oaks, CA: SAGE Publications. 
Petry, K.U. (2014). HPV and cervical cancer. Scandinavian Journal of Clinical and 
Laboratory Investigation, 74(sup244), 59-62, DOI: 
10.3109/00365513.2014.936683 
Psaki SR, Seidman JC, Miller M, Gottlieb M, Bhutta ZA, Ahmed T, Ahmed AS, Bessong 
P, John SM, Kang G, Kosek M, Lima A, Shrestha P, Svensen E, Checkley W; 
MAL-ED Network Investigators. Measuring socioeconomic status in 
79 
 
multicountry studies: results from the eight-country MAL-ED study. Popul Health 
Metr. 2014 Mar 21;12(1):8. doi: 10.1186/1478-7954-12-8. PMID: 24656134; 
PMCID: PMC4234146. 
Ramírez, A.S., Rutten, L.J.F., Oh, A., Vengoechea, B.L., Moser. R.P., Vanderpool, R.C., 
Hesse, B.W. (2013). Perceptions of cancer controllability and cancer risk 
knowledge: The moderating role of race, ethnicity, and acculturation. Journal of 
Cancer Education, 28(2), 254-61. 
Reboji, M., Pribac, L., Frederiksen, M.E., & Lynge, E. (2013). The problem of false-
positive human papillomavirus DNA tests in cervical screening. Current 
Pharmaceutical Design, 19(8), 1439-49. PMID: 23016777 
Rey-Ares, L., Ciapponi, A. & Pichon-Riviere, A. (2012). Efficacy and safety of human 
papilloma virus vaccine in cervical cancer prevention: Systematic review and 
meta-analysis. Archivos Argentinos Pediatria, 110, 483–489. 
Robinson, F. (2010). Raising awareness of cervical cancer. Practice Nurse, 40(6), 10-11.  
Ryan, R. (2012). The Oxford Handbook of Human Motivation. Oxford University Press, 
USA. 
Salz, T., Gottlieb, S. L., Smith, J. S., & Brewer, N. T. (2010). The association between 
cervical abnormalities and attitudes toward cervical cancer prevention. Journal of 
Women’s Health (15409996), 19(11), 2011-2016. doi:10.1089/jwh.2009.1790. 
Sell, K., Amella, E., Mueller, M., Andrews, J., & Wachs, J. (2016). Use of social 
cognitive theory to assess salient clinical research in chronic disease self-




Semega, J.L., Fontenot, K.R., & Kollar, M.A. (2017). Income and poverty in the United 
States: 2016. U.S. Census Bureau, Current Population Reports, P60-259. 
https://www.census.gov/content/dam/Census/library/publications/2017/demo/P60
-259.pdf. 
Signalhealth. (n.d.). What is sexual activity? https://www.signhealth.org.uk/what-is-
sexual-activity/ 
Tabatabai MA, Kengwoung-Keumo J-J, Eby WM, Bae S, Guemmegne JT, Manne U, et 
al. (2014) Disparities in Cervical Cancer Mortality Rates as Determined by the 
Longitudinal Hyperbolastic Mixed-Effects Type II Model. PLoS ONE 9(9): 
e107242. https://doi.org/10.1371/journal.pone.0107242 
Templeton, A. R. (2013). Biological races in humans. Studies in History and Philosophy 
of Biological and Biomedical Sciences, 44(3), 262–271. 
http://doi.org/10.1016/j.shpsc.2013.04.010. 
The Association Between Cervical Abnormalites and Attitudes Toward Cervial Cancer 
Prevention . (n.d.). Retrieved from researchgate: 
https://www.researchgate.net/publication/46287213_The_Association_Between_
Cervical_Abnormalities_and_Attitudes_Toward_Cervical_Cancer_Prevention 
The Use and Interpretation of Quasi-Experimental Studies in Medical Informatics. (n.d.). 






U.S. Cancer Statistics Working Group. (2017). United States Cancer Statistics: 1999– 
2014 Incidence and Mortality Web-based Report. Atlanta: U.S. Department of 
Health and Human Services, Centers for Disease Control and Prevention and 
National Cancer Institute. www.cdc.gov/uscs. 
Waters, E.A., Muff, J., & Hamilton, J.G. (2014). Multifactorial beliefs about the role of 
genetics and behavior in common health conditions: Prevalence and associations 
with participant characteristics and engagement in health behaviors. Genetics in 
Medicine, 16(12), 913-21. 
Wargo, W.G. (2015). Identifying assumptions and limitations for your dissertation. 
Menifee, CA: Academic Information Center. 
White, M.D. (2014). Pros, cons, and ethics of HPV vaccine in teens-Why such 
controversy? Translational Andrology and Urology, 3(4), 429-34. 
Williams, M., Moneyham, L., Kempf, M. C., Chamot, E., & Scarinci, I. (2015). 
Structural and sociocultural factors associated with cervical cancer screening 
among HIV-infected African American women in Alabama. AIDS Patient Care 
and STDs, 29(1), 13-9.  
 
 
 
 
 
